<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xsllu="http://xsolla.com/20260630">
    <link:schemaRef xlink:href="xsllu-20260630.xsd" xlink:type="simple"/>
    <context id="cref_1762077053">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1495117848">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-30</instant>
        </period>
    </context>
    <context id="cref_1045493571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">xsllu:MeasurementInputProbabilityOfDeSPACAndMarketAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-30</instant>
        </period>
    </context>
    <context id="cref_319446629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-30</instant>
        </period>
    </context>
    <context id="cref_1756716729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">xsllu:MeasurementInputWarrantTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-30</instant>
        </period>
    </context>
    <context id="cref_1196578209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-30</instant>
        </period>
    </context>
    <context id="cref_696371864">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-30</instant>
        </period>
    </context>
    <context id="cref_471804980">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-30</instant>
        </period>
    </context>
    <context id="cref_461618625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">xsllu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2115185240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_195483171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2057164191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1503113034">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">xsllu:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1171897513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1976784221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1867110348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">xsllu:ConditionalRedemptionOfPublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_977440093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">xsllu:ConditionalRedemptionOfPublicWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1539524353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">xsllu:ConditionalRedemptionOfPublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2113084492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">xsllu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_88531393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">xsllu:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_997179037">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">xsllu:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_96552065">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
        </entity>
        <period>
            <startDate>2026-03-11</startDate>
            <endDate>2026-03-11</endDate>
        </period>
    </context>
    <context id="cref_544972114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_993690049">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1335978175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1388846012">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_251889792">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1409571062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">xsllu:RepresentativeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_238756345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">xsllu:RepresentativeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1265438675">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_1750857422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_1456379313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">xsllu:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_1209950440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">xsllu:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_2119870965">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">xsllu:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_1596325068">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">xsllu:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_210333060">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1568216223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1664259452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">xsllu:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_989617405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">xsllu:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1916240742">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">xsllu:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-29</instant>
        </period>
    </context>
    <context id="cref_81846091">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_157639316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1966811628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_723010644">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-28</startDate>
            <endDate>2026-01-28</endDate>
        </period>
    </context>
    <context id="cref_1657735904">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-28</instant>
        </period>
    </context>
    <context id="cref_1837092599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
        </entity>
        <period>
            <startDate>2026-01-28</startDate>
            <endDate>2026-01-28</endDate>
        </period>
    </context>
    <context id="cref_735942307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">xsllu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-28</startDate>
            <endDate>2026-01-28</endDate>
        </period>
    </context>
    <context id="cref_107659405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">xsllu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-28</instant>
        </period>
    </context>
    <context id="cref_826114678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">xsllu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-28</startDate>
            <endDate>2026-01-28</endDate>
        </period>
    </context>
    <context id="cref_1578264219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">xsllu:IndependentDirectorsAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">xsllu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-28</startDate>
            <endDate>2026-01-28</endDate>
        </period>
    </context>
    <context id="cref_2032222852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-11</startDate>
            <endDate>2026-03-11</endDate>
        </period>
    </context>
    <context id="cref_642342285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-11</startDate>
            <endDate>2026-03-11</endDate>
        </period>
    </context>
    <context id="cref_1635715959">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">xsllu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_1451507070">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">xsllu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-16</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1683450615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">xsllu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-16</startDate>
            <endDate>2025-09-16</endDate>
        </period>
    </context>
    <context id="cref_1942716785">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">xsllu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-16</instant>
        </period>
    </context>
    <context id="cref_425230724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_1324287334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_626247227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-30</startDate>
            <endDate>2026-01-30</endDate>
        </period>
    </context>
    <context id="cref_498423454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">xsllu:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_994351911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">xsllu:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_2044190751">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_1666606632">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-30</startDate>
            <endDate>2026-01-30</endDate>
        </period>
    </context>
    <context id="cref_165842956">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_780012692">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_363545529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_297007133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_889404932">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1124581008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1446224866">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xsllu:ClassBNonRedeemableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_732600868">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xsllu:ClassARedeemableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1191056225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xsllu:ClassBNonRedeemableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_736587507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xsllu:ClassARedeemableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_315117842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_507656786">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1648435608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1513469378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:UnderwritersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_950170934">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_2016863650">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-30</startDate>
            <endDate>2026-01-30</endDate>
        </period>
    </context>
    <context id="cref_2043273259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-30</startDate>
            <endDate>2026-01-30</endDate>
        </period>
    </context>
    <context id="cref_743104647">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
        </entity>
        <period>
            <startDate>2025-09-16</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_958897828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:FounderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-11</startDate>
            <endDate>2026-03-11</endDate>
        </period>
    </context>
    <context id="cref_616003033">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:FounderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_571546587">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-31</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_646970134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1478212138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_376000087">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_302067816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_462053244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1859104218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_479350918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1930866084">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1793730684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_673780506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1660267742">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1231923650">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1310349575">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_376854150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_987931480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1252544791">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1721558185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_763577777">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xsllu:ClassARedeemableAndNonredeemableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1683463816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xsllu:ClassARedeemableAndNonredeemableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_258735896">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:FounderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-11</instant>
        </period>
    </context>
    <context id="cref_1919245139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">xsllu:FounderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_1990991579">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1095145361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_429750150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1924274293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-14</instant>
        </period>
    </context>
    <context id="cref_1146716111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-14</instant>
        </period>
    </context>
    <context id="cref_1407759088">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xsllu:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1059009962">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xsllu:ClassAOrdinarySharesParValue00001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_721752571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xsllu:UnitsEachConsistingOfOneClassAOrdinaryShareParValue00001PerShareAndOneHalfOfOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_285154315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1850072397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_964362215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_516428665">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1240357674">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2067856645">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1375488483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002088807</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">xsllu:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <unit id="uref_1495117848">
        <measure>pure</measure>
    </unit>
    <unit id="uref_461618625">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="uref_2055607361">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_167372933">
        <measure>shares</measure>
    </unit>
    <unit id="uref_1375488483">
        <measure>xsllu:Segment</measure>
    </unit>
    <us-gaap:Cash
      contextRef="cref_376854150"
      id="fc_1996120980"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:DeferredCosts
      contextRef="cref_2057164191"
      id="fc_1395712127"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_376854150"
      id="fc_1831742344"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_210333060"
      id="fc_1257714275"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_376854150"
      id="fc_11042936"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_2057164191"
      id="fc_154909514"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_376854150"
      id="fc_1591196334"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_2057164191"
      id="fc_298302100"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_2057164191"
      id="fc_1923879677"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_376854150"
      id="fc_458583753"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_2057164191"
      id="fc_327783228"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_376854150"
      id="fc_1995770665"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_2057164191"
      id="fc_1748378669"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_376854150"
      id="fc_1354615353"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="cref_1095145361"
      id="fc_477555050"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <xsllu:ChangeInFairValueOfOverAllotmentLiability
      contextRef="cref_195483171"
      id="fc_1425405393"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1310349575"
      id="fc_429758717"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1231923650"
      id="fc_245339642"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_673780506"
      id="fc_980566977"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="cref_1231923650"
      id="fc_107669114"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1231923650"
      id="fc_791282151"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_673780506"
      id="fc_539918560"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_673780506"
      id="fc_1178157141"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_507656786"
      id="fc_1859835130"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_1310349575"
      id="fc_1430499093"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_1231923650"
      id="fc_2083409104"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_673780506"
      id="fc_1755505602"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_1310349575"
      id="fc_1649967146"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <xsllu:StockIssuedDuringYearFairValueOfRepresentativeSharesDeferredUntilIPO
      contextRef="cref_1231923650"
      id="fc_396571739"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <xsllu:StockIssuedDuringYearFairValueOfRepresentativeSharesDeferredUntilIPOValue
      contextRef="cref_1231923650"
      id="fc_880030228"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <xsllu:StockIssuedDuringYearFairValueOfRepresentativeSharesDeferredUntilIPOValue
      contextRef="cref_673780506"
      id="fc_2012008599"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_2057164191"
      id="fc_647132504"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_2057164191"
      id="fc_679274483"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_1095145361"
      id="fc_1385144039"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_285154315"
      id="fc_285154315"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_376854150"
      id="fc_327851401"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:Cash
      contextRef="cref_376854150"
      id="fc_125873775"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1850072397"
      id="fc_1850072397"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_964362215"
      id="fc_964362215"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1310349575"
      id="fc_528591731"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1231923650"
      id="fc_1211145252"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_673780506"
      id="fc_467276172"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_964362215"
      id="fc_1690920840"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1310349575"
      id="fc_251580899"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1231923650"
      id="fc_1129424118"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1660267742"
      id="fc_605404983"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_1793730684"
      id="fc_1690827272"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_1930866084"
      id="fc_415702717"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_376854150"
      id="fc_696350577"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1095145361"
      id="fc_411385996"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_1762077053" id="fc_1393846306">http://fasb.org/srt/2026#ChiefFinancialOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_376854150"
      id="fc_904064709"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1095145361"
      id="fc_927632558"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="cref_1095145361"
      id="fc_156206911"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="cref_1762077053" id="ixv-3653">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="cref_1762077053" id="ixv-3654">0002088807</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="cref_1762077053" id="ixv-3655">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_1762077053" id="ixv-3656">Q2</dei:DocumentFiscalPeriodFocus>
    <xsllu:DueToSponsor
      contextRef="cref_376854150"
      id="fc_2139016873"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_376854150"
      id="fc_2064457719"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <xsllu:PrepaidInsurances
      contextRef="cref_376854150"
      id="fc_1020214695"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1095145361"
      id="fc_1021202129"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1095145361"
      id="fc_1652506352"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_516428665"
      id="fc_516428665"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1240357674"
      id="fc_1240357674"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_516428665"
      id="fc_1844967248"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1240357674"
      id="fc_740609882"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_462053244"
      id="fc_688667800"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_2067856645"
      id="fc_2067856645"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <xsllu:DueToSponsor
      contextRef="cref_376854150"
      id="fc_1447617457"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_376854150"
      id="fc_853235104"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <xsllu:AdvanceToRelatedParties
      contextRef="cref_376854150"
      id="fc_399071764"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:NumberOfReportableSegments
      contextRef="cref_1375488483"
      decimals="0"
      id="fc_1375488483"
      unitRef="uref_1375488483">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_2057164191"
      id="fc_253127228"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <xsllu:AmountsAccruedForInterestAndPenalties
      contextRef="cref_743104647"
      id="fc_450433021"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_285154315"
      id="fc_972943973"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <dei:EntityTaxIdentificationNumber contextRef="cref_1762077053" id="fc_110589447">00-0000000</dei:EntityTaxIdentificationNumber>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_376854150"
      id="fc_1908265980"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <xsllu:WeightedaverageSharesOutstanding
      contextRef="cref_1124581008"
      id="fc_1883514860"
      unitRef="uref_167372933"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1124581008"
      id="fc_1844104598"
      unitRef="uref_461618625"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_889404932"
      id="fc_843280090"
      unitRef="uref_461618625"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1124581008"
      id="fc_1632770492"
      unitRef="uref_461618625"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_889404932"
      id="fc_1832070373"
      unitRef="uref_461618625"
      xsi:nil="true"/>
    <us-gaap:Cash
      contextRef="cref_376854150"
      id="fc_1218061301"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_376854150"
      id="fc_1614798136"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <xsllu:AmountsAccruedForInterestAndPenalties
      contextRef="cref_1762077053"
      id="fc_2084175086"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_376854150"
      id="fc_231689279"
      unitRef="uref_2055607361"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="cref_1762077053" id="ixv-4629">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="cref_1762077053" id="ixv-4630">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="cref_1762077053" id="ixv-4631">2026-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_1762077053" id="ixv-4632">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="cref_1762077053" id="ixv-4633">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="cref_1762077053" id="ixv-4634">001-43066</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="cref_1762077053" id="ixv-4635">XSOLLA SPAC 1</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_1762077053" id="ixv-4636">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="cref_1762077053" id="ixv-4637">15260     Ventura Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="cref_1762077053" id="ixv-4638">Suite 2230</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="cref_1762077053" id="ixv-4639">Sherman Oaks</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="cref_1762077053" id="ixv-4640">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="cref_1762077053" id="ixv-4641">91403</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_1762077053" id="ixv-4642">(877)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_1762077053" id="ixv-4643">987-9233</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_721752571" id="ixv-4644">Units, each consisting of     one Class A ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_721752571" id="ixv-4645">XSLLU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_721752571" id="ixv-4646">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_1059009962" id="ixv-4647">Class A ordinary shares,     par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_1059009962" id="ixv-4648">XSLL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_1059009962" id="ixv-4649">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_1407759088" id="ixv-4650">Warrants, each whole warrant     exercisable for one Class A ordinary share at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_1407759088" id="ixv-4651">XSLLW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_1407759088" id="ixv-4652">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="cref_1762077053" id="ixv-4653">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_1762077053" id="ixv-4654">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_1762077053" id="ixv-4655">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_1762077053" id="ixv-4656">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_1762077053" id="ixv-4657">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_1762077053" id="ixv-4658">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="cref_1762077053" id="ixv-4659">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_1146716111"
      decimals="0"
      id="ixv-4660"
      unitRef="uref_167372933">20873579</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_1924274293"
      decimals="0"
      id="ixv-4661"
      unitRef="uref_167372933">6806462</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4662"
      unitRef="uref_2055607361">1750553</us-gaap:Cash>
    <xsllu:PrepaidInsurances
      contextRef="cref_2057164191"
      decimals="0"
      id="fc_1683066345"
      unitRef="uref_2055607361">46127</xsllu:PrepaidInsurances>
    <xsllu:AdvanceToRelatedParties
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4664"
      unitRef="uref_2055607361">45</xsllu:AdvanceToRelatedParties>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4665"
      unitRef="uref_2055607361">47364</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4666"
      unitRef="uref_2055607361">4673</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4667"
      unitRef="uref_2055607361">1844089</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4668"
      unitRef="uref_2055607361">4673</us-gaap:AssetsCurrent>
    <us-gaap:DeferredCosts
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4669"
      unitRef="uref_2055607361">218347</us-gaap:DeferredCosts>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4670"
      unitRef="uref_2055607361">207159708</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4671"
      unitRef="uref_2055607361">209003797</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4672"
      unitRef="uref_2055607361">223020</us-gaap:Assets>
    <xsllu:AccruedOfferingCosts
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4673"
      unitRef="uref_2055607361">75000</xsllu:AccruedOfferingCosts>
    <xsllu:AccruedOfferingCosts
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4674"
      unitRef="uref_2055607361">28267</xsllu:AccruedOfferingCosts>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4675"
      unitRef="uref_2055607361">115974</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4676"
      unitRef="uref_2055607361">5000</us-gaap:AccruedLiabilitiesCurrent>
    <xsllu:DueToSponsor
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4677"
      unitRef="uref_2055607361">100000</xsllu:DueToSponsor>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4678"
      unitRef="uref_2055607361">114124</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_429750150"
      decimals="0"
      id="ixv-4679"
      unitRef="uref_2055607361">241415</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4680"
      unitRef="uref_2055607361">405098</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4681"
      unitRef="uref_2055607361">274682</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4682"
      unitRef="uref_2055607361">405098</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4683"
      unitRef="uref_2055607361">274682</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="cref_251889792"
      decimals="4"
      id="ixv-4684"
      unitRef="uref_461618625">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="cref_1095145361"
      decimals="4"
      id="ixv-4685"
      unitRef="uref_461618625">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="cref_251889792"
      decimals="0"
      id="ixv-4686"
      unitRef="uref_167372933">20419385</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_251889792"
      decimals="2"
      id="ixv-4687"
      unitRef="uref_461618625">10.15</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_1095145361"
      decimals="0"
      id="ixv-4688"
      unitRef="uref_461618625">0</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4689"
      unitRef="uref_2055607361">207159708</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_2057164191"
      decimals="4"
      id="ixv-4690"
      unitRef="uref_461618625">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_376854150"
      decimals="4"
      id="ixv-4691"
      unitRef="uref_461618625">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4692"
      unitRef="uref_167372933">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4693"
      unitRef="uref_167372933">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_251889792"
      decimals="4"
      id="ixv-4694"
      unitRef="uref_461618625">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1095145361"
      decimals="4"
      id="ixv-4695"
      unitRef="uref_461618625">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_251889792"
      decimals="0"
      id="ixv-4696"
      unitRef="uref_167372933">475000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1095145361"
      decimals="0"
      id="ixv-4697"
      unitRef="uref_167372933">475000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_251889792"
      decimals="0"
      id="ixv-4698"
      unitRef="uref_167372933">454194</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_251889792"
      decimals="0"
      id="ixv-4699"
      unitRef="uref_167372933">454194</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_251889792"
      decimals="0"
      id="ixv-4700"
      unitRef="uref_2055607361">45</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1388846012"
      decimals="4"
      id="ixv-4701"
      unitRef="uref_461618625">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1335978175"
      decimals="4"
      id="ixv-4702"
      unitRef="uref_461618625">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1388846012"
      decimals="0"
      id="ixv-4703"
      unitRef="uref_167372933">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1335978175"
      decimals="0"
      id="ixv-4704"
      unitRef="uref_167372933">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1388846012"
      decimals="0"
      id="ixv-4705"
      unitRef="uref_167372933">6806462</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1388846012"
      decimals="0"
      id="ixv-4706"
      unitRef="uref_167372933">6806462</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1335978175"
      decimals="0"
      id="ixv-4707"
      unitRef="uref_167372933">7666667</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1335978175"
      decimals="0"
      id="ixv-4708"
      unitRef="uref_167372933">7666667</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_1388846012"
      decimals="0"
      id="fc_1510873683"
      unitRef="uref_2055607361">680</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="cref_1335978175"
      decimals="0"
      id="fc_831437636"
      unitRef="uref_2055607361">767</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4711"
      unitRef="uref_2055607361">24233</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4712"
      unitRef="uref_2055607361">1438266</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4713"
      unitRef="uref_2055607361">-76662</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4714"
      unitRef="uref_2055607361">1438991</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4715"
      unitRef="uref_2055607361">-51662</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4716"
      unitRef="uref_2055607361">209003797</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4717"
      unitRef="uref_2055607361">223020</us-gaap:LiabilitiesAndStockholdersEquity>
    <xsllu:UnderwritersForfeitedShares
      contextRef="cref_1990991579"
      decimals="0"
      id="ixv-4719"
      unitRef="uref_167372933">1000000</xsllu:UnderwritersForfeitedShares>
    <xsllu:StockIssuedDuringThePeriodNoLongerSubjectToForfeitures
      contextRef="cref_1919245139"
      decimals="0"
      id="ixv-4720"
      unitRef="uref_167372933">139795</xsllu:StockIssuedDuringThePeriodNoLongerSubjectToForfeitures>
    <xsllu:StockIssuedDuringThePeriodNoLongerSubjectToForfeitures
      contextRef="cref_258735896"
      decimals="0"
      id="ixv-4721"
      unitRef="uref_167372933">860205</xsllu:StockIssuedDuringThePeriodNoLongerSubjectToForfeitures>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_195483171"
      decimals="0"
      id="ixv-4722"
      unitRef="uref_2055607361">145106</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4723"
      unitRef="uref_2055607361">368468</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_195483171"
      decimals="0"
      id="ixv-4724"
      unitRef="uref_2055607361">-145106</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4725"
      unitRef="uref_2055607361">-368468</us-gaap:OperatingIncomeLoss>
    <xsllu:ChangeInFairValueOfOverAllotmentLiability
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4726"
      unitRef="uref_2055607361">-160600</xsllu:ChangeInFairValueOfOverAllotmentLiability>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_195483171"
      decimals="0"
      id="ixv-4727"
      unitRef="uref_2055607361">1800222</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4728"
      unitRef="uref_2055607361">2965858</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_195483171"
      decimals="0"
      id="ixv-4729"
      unitRef="uref_2055607361">1800222</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4730"
      unitRef="uref_2055607361">3126458</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="cref_195483171"
      decimals="0"
      id="ixv-4731"
      unitRef="uref_2055607361">1655116</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4732"
      unitRef="uref_2055607361">2757990</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1683463816"
      decimals="0"
      id="ixv-4733"
      unitRef="uref_167372933">20873579</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1683463816"
      decimals="0"
      id="ixv-4734"
      unitRef="uref_167372933">20873579</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_763577777"
      decimals="0"
      id="ixv-4735"
      unitRef="uref_167372933">17406850</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_763577777"
      decimals="0"
      id="ixv-4736"
      unitRef="uref_167372933">17406850</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1683463816"
      decimals="2"
      id="ixv-4737"
      unitRef="uref_461618625">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1683463816"
      decimals="2"
      id="ixv-4738"
      unitRef="uref_461618625">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_763577777"
      decimals="2"
      id="ixv-4739"
      unitRef="uref_461618625">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_763577777"
      decimals="2"
      id="ixv-4740"
      unitRef="uref_461618625">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1191056225"
      decimals="0"
      id="fc_1120036541"
      unitRef="uref_167372933">6806462</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1191056225"
      decimals="0"
      id="fc_278179953"
      unitRef="uref_167372933">6806462</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1446224866"
      decimals="0"
      id="fc_306520301"
      unitRef="uref_167372933">6780975</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1446224866"
      decimals="0"
      id="fc_1275346653"
      unitRef="uref_167372933">6780975</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1191056225"
      decimals="2"
      id="ixv-4745"
      unitRef="uref_461618625">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1191056225"
      decimals="2"
      id="ixv-4746"
      unitRef="uref_461618625">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1446224866"
      decimals="2"
      id="ixv-4747"
      unitRef="uref_461618625">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1446224866"
      decimals="2"
      id="ixv-4748"
      unitRef="uref_461618625">0.11</us-gaap:EarningsPerShareDiluted>
    <xsllu:FounderSharesWereSubjectToForfeiture
      contextRef="cref_571546587"
      decimals="0"
      id="ixv-4750"
      unitRef="uref_167372933">1000000</xsllu:FounderSharesWereSubjectToForfeiture>
    <xsllu:NumberOfSharesNoLongerSubjectToForfeitures
      contextRef="cref_616003033"
      decimals="0"
      id="ixv-4751"
      unitRef="uref_167372933">139795</xsllu:NumberOfSharesNoLongerSubjectToForfeitures>
    <xsllu:FounderSharesWereSubjectToForfeiture
      contextRef="cref_958897828"
      decimals="0"
      id="ixv-4752"
      unitRef="uref_167372933">860205</xsllu:FounderSharesWereSubjectToForfeiture>
    <us-gaap:SharesOutstanding
      contextRef="cref_1721558185"
      decimals="0"
      id="fc_1963566780"
      unitRef="uref_167372933">7666667</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1721558185"
      decimals="0"
      id="fc_1721558185"
      unitRef="uref_2055607361">767</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1252544791"
      decimals="0"
      id="ixv-4755"
      unitRef="uref_2055607361">24233</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_987931480"
      decimals="0"
      id="ixv-4756"
      unitRef="uref_2055607361">-76662</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_376854150"
      decimals="0"
      id="ixv-4757"
      unitRef="uref_2055607361">-51662</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1660267742"
      decimals="0"
      id="ixv-4758"
      unitRef="uref_2055607361">7402378</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_507656786"
      decimals="0"
      id="ixv-4759"
      unitRef="uref_2055607361">7402378</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <xsllu:SaleOfPrivatePlacementUnits
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4760"
      unitRef="uref_167372933">403146</xsllu:SaleOfPrivatePlacementUnits>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="cref_1310349575"
      decimals="0"
      id="ixv-4761"
      unitRef="uref_167372933">403146</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1310349575"
      decimals="0"
      id="ixv-4762"
      unitRef="uref_2055607361">40</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_1660267742"
      decimals="0"
      id="ixv-4763"
      unitRef="uref_2055607361">4031420</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="cref_507656786"
      decimals="0"
      id="ixv-4764"
      unitRef="uref_2055607361">4031460</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1660267742"
      decimals="0"
      id="ixv-4765"
      unitRef="uref_2055607361">3471295</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_507656786"
      decimals="0"
      id="ixv-4766"
      unitRef="uref_2055607361">3471295</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <xsllu:StockIssuedDuringYearFairValueOfRepresentativeSharesDeferredUntilIPO
      contextRef="cref_1310349575"
      decimals="0"
      id="ixv-4767"
      unitRef="uref_167372933">51048</xsllu:StockIssuedDuringYearFairValueOfRepresentativeSharesDeferredUntilIPO>
    <xsllu:StockIssuedDuringYearFairValueOfRepresentativeSharesDeferredUntilIPOValue
      contextRef="cref_1310349575"
      decimals="0"
      id="ixv-4768"
      unitRef="uref_2055607361">5</xsllu:StockIssuedDuringYearFairValueOfRepresentativeSharesDeferredUntilIPOValue>
    <xsllu:StockIssuedDuringYearFairValueOfRepresentativeSharesDeferredUntilIPOValue
      contextRef="cref_1660267742"
      decimals="0"
      id="ixv-4769"
      unitRef="uref_2055607361">501797</xsllu:StockIssuedDuringYearFairValueOfRepresentativeSharesDeferredUntilIPOValue>
    <xsllu:StockIssuedDuringYearFairValueOfRepresentativeSharesDeferredUntilIPOValue
      contextRef="cref_507656786"
      decimals="0"
      id="ixv-4770"
      unitRef="uref_2055607361">501802</xsllu:StockIssuedDuringYearFairValueOfRepresentativeSharesDeferredUntilIPOValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_1660267742"
      decimals="0"
      id="ixv-4771"
      unitRef="uref_2055607361">69294</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_507656786"
      decimals="0"
      id="ixv-4772"
      unitRef="uref_2055607361">69294</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_1231923650"
      decimals="0"
      id="fc_522668487"
      unitRef="uref_167372933">-860205</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_1231923650"
      decimals="0"
      id="fc_1231923650"
      unitRef="uref_2055607361">-87</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_1660267742"
      decimals="0"
      id="ixv-4775"
      unitRef="uref_2055607361">87</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:NetIncomeLoss
      contextRef="cref_673780506"
      decimals="0"
      id="ixv-4776"
      unitRef="uref_2055607361">1102874</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_507656786"
      decimals="0"
      id="ixv-4777"
      unitRef="uref_2055607361">1102874</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="cref_1793730684"
      decimals="0"
      id="ixv-4778"
      unitRef="uref_2055607361">45</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1930866084"
      decimals="0"
      id="fc_1930866084"
      unitRef="uref_2055607361">680</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_479350918"
      decimals="0"
      id="ixv-4780"
      unitRef="uref_2055607361">557160</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1859104218"
      decimals="0"
      id="ixv-4781"
      unitRef="uref_2055607361">1026212</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_315117842"
      decimals="0"
      id="ixv-4782"
      unitRef="uref_2055607361">1584097</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_462053244"
      decimals="0"
      id="ixv-4783"
      unitRef="uref_2055607361">-557160</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_302067816"
      decimals="0"
      id="ixv-4784"
      unitRef="uref_2055607361">-1243062</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_195483171"
      decimals="0"
      id="ixv-4785"
      unitRef="uref_2055607361">1800222</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_302067816"
      decimals="0"
      id="ixv-4786"
      unitRef="uref_2055607361">1655116</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_195483171"
      decimals="0"
      id="ixv-4787"
      unitRef="uref_2055607361">1655116</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_376000087"
      decimals="0"
      id="ixv-4788"
      unitRef="uref_167372933">454194</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_376000087"
      decimals="0"
      id="ixv-4789"
      unitRef="uref_2055607361">45</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_1478212138"
      decimals="0"
      id="fc_1583060497"
      unitRef="uref_167372933">6806462</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1478212138"
      decimals="0"
      id="fc_1478212138"
      unitRef="uref_2055607361">680</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_646970134"
      decimals="0"
      id="ixv-4792"
      unitRef="uref_2055607361">1438266</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4793"
      unitRef="uref_2055607361">1438991</us-gaap:StockholdersEquity>
    <xsllu:ForfeitedFounderShares
      contextRef="cref_571546587"
      decimals="0"
      id="fc_571546587"
      unitRef="uref_167372933">1000000</xsllu:ForfeitedFounderShares>
    <xsllu:NumberOfSharesNoLongerSubjectToForfeiture
      contextRef="cref_616003033"
      decimals="0"
      id="ixv-4796"
      unitRef="uref_167372933">139795</xsllu:NumberOfSharesNoLongerSubjectToForfeiture>
    <xsllu:SponsorSurrenderedFounderShares
      contextRef="cref_958897828"
      decimals="0"
      id="fc_958897828"
      unitRef="uref_167372933">860205</xsllu:SponsorSurrenderedFounderShares>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4798"
      unitRef="uref_2055607361">2757990</us-gaap:NetIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4799"
      unitRef="uref_2055607361">2965858</us-gaap:InvestmentIncomeInterest>
    <xsllu:PaymentOfFormationGeneralAndAdministrativeCostsThroughPromissoryNoteRelatedParty
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4800"
      unitRef="uref_2055607361">46945</xsllu:PaymentOfFormationGeneralAndAdministrativeCostsThroughPromissoryNoteRelatedParty>
    <xsllu:ChangeInFairValueOfOverAllotmentLiability
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4801"
      unitRef="uref_2055607361">-160600</xsllu:ChangeInFairValueOfOverAllotmentLiability>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4802"
      unitRef="uref_2055607361">42691</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4803"
      unitRef="uref_2055607361">110974</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4804"
      unitRef="uref_2055607361">-253240</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4805"
      unitRef="uref_2055607361">204193850</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4806"
      unitRef="uref_2055607361">-204193850</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4807"
      unitRef="uref_2055607361">202662396</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4808"
      unitRef="uref_2055607361">4031460</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <xsllu:ProceedFromAdvancesFromRelatedParty
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4809"
      unitRef="uref_2055607361">-45</xsllu:ProceedFromAdvancesFromRelatedParty>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4810"
      unitRef="uref_2055607361">114124</us-gaap:ProceedsFromRelatedPartyDebt>
    <xsllu:ProceedsFromDueToSponsor
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4811"
      unitRef="uref_2055607361">53873</xsllu:ProceedsFromDueToSponsor>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4812"
      unitRef="uref_2055607361">316235</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4813"
      unitRef="uref_2055607361">347930</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4814"
      unitRef="uref_2055607361">206197643</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4815"
      unitRef="uref_2055607361">1750553</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4816"
      unitRef="uref_2055607361">1750553</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <xsllu:DeferredOfferingCostsIncludedInAccruedOfferingCosts
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4817"
      unitRef="uref_2055607361">75000</xsllu:DeferredOfferingCostsIncludedInAccruedOfferingCosts>
    <xsllu:DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4818"
      unitRef="uref_2055607361">27875</xsllu:DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4819"
      unitRef="uref_2055607361">9202600</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <xsllu:FairValueOfRepresentativeShares
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4820"
      unitRef="uref_2055607361">501802</xsllu:FairValueOfRepresentativeShares>
    <xsllu:OverAllotmentOptionLiability
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4821"
      unitRef="uref_2055607361">160600</xsllu:OverAllotmentOptionLiability>
    <xsllu:ForfeitureOfFounderShares
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4822"
      unitRef="uref_2055607361">87</xsllu:ForfeitureOfFounderShares>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="cref_1762077053" id="ixv-2010">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 1 &#x2014;&#160;DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS &lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; Xsolla SPAC 1 (the &#x201c;Company&#x201d;) is a blank check company incorporated as a Cayman Islands exempted corporation on September&#160;16, 2025. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the &#x201c;Business Combination&#x201d;). The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target with respect to an initial Business Combination with the Company. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; As of June 30, 2026, the Company had not commenced any operations. All activity for the period from September&#160;16, 2025 (inception) through June 30, 2026 relates to the Company&#x2019;s formation, the initial public offering (&#x201c;Initial Public Offering,&#x201d; as defined below) and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income on the proceeds derived from the Initial Public Offering.&#160;The Company has selected December&#160;31 as its fiscal year end. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on January 28, 2026. On January 30, 2026, the Company consummated the Initial Public Offering of 20,000,000 units (the &#x201c;Units&#x201d;), at $10.00 per Unit, generating gross proceeds of $200,000,000. Each Unit consists of one Class A ordinary share (each, a &#x201c;Public Share&#x201d;) and one-half of one redeemable warrant (each, a &#x201c;Public Warrant&#x201d;). Each whole Public Warrant entitles the holder thereof to purchase one Class&#160;A ordinary share at a price of $11.50 per share, subject to adjustment as described in the Company&#x2019;s prospectus. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 400,000 private placement units (the &#x201c;Private Placement Units&#x201d;) at a price of $10.00 per Private Placement Unit, in a private placement to the Company&#x2019;s sponsor, Xsolla SPAC I LLC (the &#x201c;Sponsor&#x201d;), generating gross proceeds of $4,000,000. Each Private Placement Unit consists of one Class&#160;A ordinary share and one-half of one warrant (&#x201c;Private Placement Warrant&#x201d;). Each whole Private Placement Warrant entitles the holder thereof to purchase one Class&#160;A ordinary share at a price of $11.50 per share, subject to adjustment, terms and limitations as described in the Company&#x2019;s prospectus. The Private Placement Units are identical to the Units sold in the Initial Public Offering, subject to certain limited exceptions as described in the Company&#x2019;s prospectus. The Private Placement Warrants included within the Private Placement Units are identical to the Public Warrants, except that they are subject to certain transfer, redemption and other provisions as described elsewhere in these financial statements and the Company&#x2019;s prospectus. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; On February 2, 2026, the Company consummated the closing of an additional 419,385 Units sold pursuant to the underwriters&#x2019; partial exercise of their over-allotment option, generating gross proceeds of $4,193,850. Simultaneously with the consummation of the partial exercise of the over-allotment option, the Company also consummated the sale of an additional 3,146 Private Placement Units to the Sponsor at a price of $10.00 per Private Placement Unit, generating gross proceeds of $31,460. Gross proceeds from the additional Units and additional Private Placement Units totaled $4,225,310. The underwriters were entitled to a cash underwriting discount of $0.075 per additional Unit, or $31,460 in the aggregate, paid on February 2, 2026. Following payment of the underwriting discount, net proceeds of $4,193,850 were deposited into the Trust Account on February 2, 2026. &lt;/p&gt;            &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; Transaction costs amounted to $2,674,141, consisting of $1,531,454 of cash underwriting discount, $501,802 representing fair value of representative shares issued to the representative of the underwriters, and $640,885 of other offering costs. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the Permitted Withdrawals on the interest income earned on the funds held in the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act&#160;of&#160;1940, as amended (the &#x201c;Investment Company Act&#x201d;). There is no assurance that the Company will be able to successfully effect a Business Combination. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; Following the closing of the Initial Public Offering on January 30, 2026, an amount of $200,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units and the Private Placement Units was placed in a trust account (the &#x201c;Trust Account&#x201d;), with U.S.-based trust account, Odyssey Transfer &amp;amp; Trust Company acting as trustee. The funds may only be invested in U.S.&#160;government securities, within the meaning set forth in Section&#160;2(a)(16)&#160;of the Investment Company Act, with a maturity of 185&#160;days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S.&#160;Treasuries and meeting certain conditions under Rule&#160;2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i)&#160;the completion of a Business Combination and (ii)&#160;the distribution of the funds in the Trust Account to the Company&#x2019;s shareholders, as described below. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company will provide the holders of the outstanding Public Shares (the &#x201c;Public Shareholders&#x201d;) with the opportunity to redeem all or a portion of their Public Shares either (i)&#160;in connection with a general meeting called to approve the Business Combination or (ii)&#160;by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest then in the Trust Account). There will be no redemption rights upon the completion of a Business Combination with respect to the Private Placement Units. The Public Shares subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&#160;480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires a resolution be passed by a simple majority of the holders of the Class&#160;A ordinary shares, par value $0.0001 (the &#x201c;Class&#160;A ordinary shares&#x201d;) and the Class&#160;B ordinary shares, par value $0.0001 (the &#x201c;Class&#160;B ordinary shares,&#x201d; and together with the Class&#160;A ordinary shares, the &#x201c;ordinary shares&#x201d;) that, being entitled to do so, attend and vote in person or by proxy at a general meeting of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the &#x201c;Articles&#x201d;), conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor, officers, and directors have agreed to vote their Founder Shares (as defined in Note&#160;5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination and waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting and, if they do vote, irrespective of whether they vote for or against the proposed Business Combination. &lt;/p&gt;           &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, the Articles provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section&#160;13 of the Securities Exchange&#160;Act&#160;of&#160;1934, as amended (the &#x201c;Exchange&#160;Act&#x201d;)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company&#x2019;s prior written consent. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Sponsor, officers, and directors have agreed (a)&#160;to waive their redemption rights with respect to any Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b)&#160;not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i)&#160;to modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with the Company&#x2019;s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii)&#160;with respect to any other provision relating to shareholder&#x2019;s rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; If the Company has not completed a Business Combination within 24&#160;months from the closing of the Initial Public Offering (the &#x201c;Combination Period&#x201d;), the Company will (i)&#160;cease all operations except for the purpose of winding up, (ii)&#160;as promptly as reasonably possible but not more than ten&#160;business days thereafter, redeem the Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders&#x2019; rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law; and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company&#x2019;s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Sponsor, officers, and directors have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares they held if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor, officers, and directors or any of their respective affiliates acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company&#x2019;s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i)&#160;$10.00 per Public Share and (ii)&#160;the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has it independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations, and we believe that the Sponsor&#x2019;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for the Company&#x2019;s initial Business Combination and redemptions could be reduced to less than $10.00 per Public Share. In such event, the Company may not be able to complete its initial Business Combination, and the Public Shareholders would receive such lesser amount per share in connection with any redemption of their Public Shares. None of the Company&#x2019;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. &lt;/p&gt;           &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Risks and Uncertainties&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Various social and political circumstances in the U.S.&#160;and around the world (including wars and other forms of conflict, including rising trade tensions between the United&#160;States and China, and other uncertainties regarding actual and potential shifts in the U.S.&#160;and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may contribute to increased market volatility and economic uncertainties or deterioration in the U.S.&#160;and worldwide. Specifically, the rising conflict between Russia and Ukraine, and the rising conflicts in the Middle East, and resulting market volatility could adversely affect the Company&#x2019;s ability to complete a business combination. In response to the conflict between Russia and Ukraine, the U.S.&#160;and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company&#x2019;s ability to complete a Business Combination and the value of the Company&#x2019;s securities. The unaudited financial statements do not include any adjustments that might result from the outcome of these uncertainties.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="cref_1762077053" id="ixv-4823">2025-09-16</dei:EntityIncorporationDateOfIncorporation>
    <xsllu:YearOfInception contextRef="cref_743104647" id="ixv-4824">September&#160;16, 2025 (inception) through June 30, 2026</xsllu:YearOfInception>
    <xsllu:NumberOfUnitsIssued
      contextRef="cref_1666606632"
      decimals="0"
      id="ixv-4825"
      unitRef="uref_167372933">20000000</xsllu:NumberOfUnitsIssued>
    <xsllu:NumberOfUnitsIssuedPricePerShare
      contextRef="cref_1666606632"
      decimals="2"
      id="ixv-4826"
      unitRef="uref_461618625">10</xsllu:NumberOfUnitsIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1666606632"
      decimals="0"
      id="ixv-4827"
      unitRef="uref_2055607361">200000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <xsllu:NumberOfUnitsIssuedPricePerShare
      contextRef="cref_2043273259"
      decimals="2"
      id="ixv-4828"
      unitRef="uref_461618625">11.5</xsllu:NumberOfUnitsIssuedPricePerShare>
    <xsllu:NumberOfUnitsIssued
      contextRef="cref_626247227"
      decimals="0"
      id="ixv-4829"
      unitRef="uref_167372933">400000</xsllu:NumberOfUnitsIssued>
    <xsllu:NumberOfUnitsIssuedPricePerShare
      contextRef="cref_626247227"
      decimals="2"
      id="ixv-4830"
      unitRef="uref_461618625">10</xsllu:NumberOfUnitsIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_626247227"
      decimals="0"
      id="ixv-4831"
      unitRef="uref_2055607361">4000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <xsllu:NumberOfUnitsIssuedPricePerShare
      contextRef="cref_2016863650"
      decimals="2"
      id="ixv-4832"
      unitRef="uref_461618625">11.5</xsllu:NumberOfUnitsIssuedPricePerShare>
    <xsllu:NumberOfUnitsIssued
      contextRef="cref_950170934"
      decimals="0"
      id="ixv-4833"
      unitRef="uref_167372933">419385</xsllu:NumberOfUnitsIssued>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_950170934"
      decimals="0"
      id="ixv-4834"
      unitRef="uref_2055607361">4193850</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <xsllu:NumberOfUnitsIssued
      contextRef="cref_1324287334"
      decimals="0"
      id="ixv-4835"
      unitRef="uref_167372933">3146</xsllu:NumberOfUnitsIssued>
    <xsllu:NumberOfUnitsIssuedPricePerShare
      contextRef="cref_1324287334"
      decimals="2"
      id="ixv-4836"
      unitRef="uref_461618625">10</xsllu:NumberOfUnitsIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1265438675"
      decimals="0"
      id="ixv-4837"
      unitRef="uref_2055607361">31460</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1513469378"
      decimals="0"
      id="ixv-4838"
      unitRef="uref_2055607361">4225310</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <xsllu:CashUnderwritingDiscountPerUnit
      contextRef="cref_1513469378"
      decimals="3"
      id="ixv-4839"
      unitRef="uref_461618625">0.075</xsllu:CashUnderwritingDiscountPerUnit>
    <us-gaap:OtherUnderwritingExpense
      contextRef="cref_1513469378"
      decimals="0"
      id="ixv-4840"
      unitRef="uref_2055607361">31460</us-gaap:OtherUnderwritingExpense>
    <xsllu:ProceedFromUnderwritingDiscount
      contextRef="cref_1265438675"
      decimals="0"
      id="ixv-4841"
      unitRef="uref_2055607361">4193850</xsllu:ProceedFromUnderwritingDiscount>
    <xsllu:TransactionCosts
      contextRef="cref_1648435608"
      decimals="0"
      id="ixv-4842"
      unitRef="uref_2055607361">2674141</xsllu:TransactionCosts>
    <us-gaap:OtherUnderwritingExpense
      contextRef="cref_1648435608"
      decimals="0"
      id="ixv-4843"
      unitRef="uref_2055607361">1531454</us-gaap:OtherUnderwritingExpense>
    <xsllu:CashUnderwritingFees
      contextRef="cref_1648435608"
      decimals="0"
      id="ixv-4844"
      unitRef="uref_2055607361">501802</xsllu:CashUnderwritingFees>
    <xsllu:DeferredUnderwritingCommissions
      contextRef="cref_1648435608"
      decimals="0"
      id="ixv-4845"
      unitRef="uref_2055607361">640885</xsllu:DeferredUnderwritingCommissions>
    <xsllu:MinimumFairMarketValueOfTrustAssets
      contextRef="cref_1762077053"
      decimals="2"
      id="ixv-4846"
      unitRef="uref_1495117848">0.80</xsllu:MinimumFairMarketValueOfTrustAssets>
    <xsllu:MinimumIssuedAndOutstandingVotingSecuritiesOwnership
      contextRef="cref_1762077053"
      decimals="2"
      id="ixv-4847"
      unitRef="uref_1495117848">0.50</xsllu:MinimumIssuedAndOutstandingVotingSecuritiesOwnership>
    <xsllu:NetProceedsFromInitialPublicOffering
      contextRef="cref_157639316"
      decimals="0"
      id="ixv-4848"
      unitRef="uref_2055607361">200000000</xsllu:NetProceedsFromInitialPublicOffering>
    <xsllu:NumberOfUnitsIssuedPricePerShare
      contextRef="cref_157639316"
      decimals="2"
      id="ixv-4849"
      unitRef="uref_461618625">10</xsllu:NumberOfUnitsIssuedPricePerShare>
    <xsllu:AnticipatedPricePerShare
      contextRef="cref_1762077053"
      decimals="2"
      id="ixv-4850"
      unitRef="uref_461618625">10</xsllu:AnticipatedPricePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_251889792"
      decimals="4"
      id="ixv-4851"
      unitRef="uref_461618625">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1388846012"
      decimals="4"
      id="ixv-4852"
      unitRef="uref_461618625">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <xsllu:AggregatePercentageOfPublicShares
      contextRef="cref_1762077053"
      decimals="2"
      id="ixv-4853"
      unitRef="uref_1495117848">0.15</xsllu:AggregatePercentageOfPublicShares>
    <xsllu:PercentageOfRedemptionOfPublicSharesOnBusinessCombination
      contextRef="cref_1762077053"
      decimals="2"
      id="ixv-4854"
      unitRef="uref_1495117848">1</xsllu:PercentageOfRedemptionOfPublicSharesOnBusinessCombination>
    <xsllu:PeriodAvailableForCompletingBusinessCombination contextRef="cref_1762077053" id="ixv-4855">P24M</xsllu:PeriodAvailableForCompletingBusinessCombination>
    <xsllu:InterestToPayDissolutionExpenses
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4856"
      unitRef="uref_2055607361">100000</xsllu:InterestToPayDissolutionExpenses>
    <xsllu:PublicOfferingPricePerUnit
      contextRef="cref_1648435608"
      decimals="2"
      id="ixv-4857"
      unitRef="uref_461618625">10</xsllu:PublicOfferingPricePerUnit>
    <xsllu:TrustAccountMinimumAmountPerPublicShare
      contextRef="cref_1762077053"
      decimals="2"
      id="ixv-4858"
      unitRef="uref_461618625">10</xsllu:TrustAccountMinimumAmountPerPublicShare>
    <xsllu:ActualAmountPerPublicShareHeld
      contextRef="cref_1762077053"
      decimals="2"
      id="ixv-4859"
      unitRef="uref_461618625">10</xsllu:ActualAmountPerPublicShareHeld>
    <xsllu:FundsAvailableThresholdPerPublicShare
      contextRef="cref_1762077053"
      decimals="2"
      id="ixv-4860"
      unitRef="uref_461618625">10</xsllu:FundsAvailableThresholdPerPublicShare>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_1762077053" id="ixv-2097">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 2 &#x2014;&#160;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in unaudited financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The accompanying unaudited financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K. As of December 31, 2025 and for the period from September 16, 2025 (inception) through December 31, 2025, filed with the SEC on March 31, 2026. The interim results for the three and six months ended June 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Emerging Growth Company&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act&#160;of&#160;1933, as amended (the &#x201c;Securities Act&#x201d;), as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012, as amended (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act&#160;of&#160;2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;           &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s unaudited financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The preparation of unaudited financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited financial statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company considers all short-term investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company had $1,750,553 and $&lt;span style="-sec-ix-hidden:fc_1218061301;"&gt;0&lt;/span&gt; of cash and no cash equivalents as of June 30, 2026 and December 31, 2025, respectively. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Investments Held in Trust Account&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; As of June 30, 2026, the assets held in the Trust Account, amounting to $207,159,708, were held in a money market account. As of December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_231689279;"&gt;no&lt;/span&gt; assets held in the Trust Account. &lt;/p&gt;   &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of June 30, 2026, the Company held cash balances in excess of federally insured limits. The Company has not experienced any losses on such accounts and management believes the Company is not exposed to significant risks on such accounts. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Offering Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The Company complies with the requirements of the FASB ASC&#160;Topic 340-10-S99-1 and SEC Staff Accounting Bulletin Topic&#160;5A&#160;&#x2014;&#160;&#x201c;Expenses of Offering&#x201d; and Topic&#160;5T&#160;&#x2014;&#160;&#x201c;Accounting for Expenses or Liabilities Paid by Principal Shareholder(s).&#x201d; Offering costs consist of costs incurred in connection with preparation for the Initial Public Offering, which include professional and registration fees incurred. FASB ASC&#160;Topic 470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units&#160;between Class&#160;A ordinary shares and warrants, prorate, allocating the Initial Public Offering proceeds to the assigned value of the warrants and to the Class&#160;A ordinary shares. Offering costs allocated to the Public Shares are charged to temporary equity and offering costs allocated to the Public Warrants and Private Placement Units are charged to shareholders&#x2019; equity as Public Warrants and Private Placement Warrants included in the Private Placement Units after management&#x2019;s evaluation are accounted for under equity treatment.&lt;/p&gt;           &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company follows the asset and liability method of accounting for income taxes under FASB ASC&#160;Topic 740, &#x201c;Income Taxes.&#x201d; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the unaudited financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. FASB ASC&#160;Topic 740 prescribes a recognition threshold and a measurement attribute for the unaudited financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were &lt;span style="-sec-ix-hidden:fc_253127228;"&gt;&lt;span style="-sec-ix-hidden:fc_1614798136;"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_450433021;"&gt;&lt;span style="-sec-ix-hidden:fc_2084175086;"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties as of June 30, 2026 and December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s unaudited financial statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;Topic 820, &#x201c;Fair Value Measurement,&#x201d; approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Derivative Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging.&#x201d; For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet date. The underwriters&#x2019; over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and are accounted for as a liability pursuant to FASB ASC Topic 480 as the underwriters did not exercise their over-allotment option at the time of the Initial Public Offering. As of June 30, 2026, the underwriters&#x2019; over-allotment option has expired and, accordingly, no related liability is recognized in the Company&#x2019;s balance sheet.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Warrant Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company accounts for the Public Warrants issued in connection with the Initial Public Offering and the Private Placement Warrants in accordance with the guidance contained in FASB ASC&#160;Topic 815, &#x201c;Derivatives and Hedging.&#x201d; Under FASB ASC&#160;Topic 815-40, the Public Warrants and the Private Placement Warrants included in the Private Placement Units meet the criteria for equity treatment and as such are recorded in shareholders&#x2019; equity. If the Public Warrants and Private Placement Warrants no longer meet the criteria for equity treatment, they will be recorded as a liability and remeasured each period with changes recorded in the unaudited statements of operations. As of June 30, 2026, there are 10,209,693 Public Warrants and 201,573 Private Placement Warrants issued and outstanding, reflecting the exercise of the underwriters&#x2019; over-allotment option. As of December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_972943973;"&gt;no&lt;/span&gt; Warrants outstanding. &lt;/p&gt;           &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Share-Based Payment Arrangements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.45pt;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The Company accounts for share awards in accordance with FASB ASC Topic 718, &#x201c;Compensation&#x2014;Stock Compensation,&#x201d; which requires that all equity awards be accounted for at their &#x201c;fair value.&#x201d; Fair value is measured on the grant date and is equal to the underlying value of the share.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.45pt;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, in the period of grant for awards that vest immediately and have no future service condition, or in the period the awards vest immediately after meeting a performance condition becomes probable (i.e., the occurrence of a Business Combination). For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company&#x2019;s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is&#160;forfeited.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.45pt;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with FASB ASC Topic 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of the Public Shares will result in charges against additional paid-in capital (to the extent available) and then accumulated deficit. Accordingly, as of June 30, 2026, the 20,419,385 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; equity section of the Company&#x2019;s balance sheets. As of June 30, 2026, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table: &lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: justify;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;204,193,850&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify;"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(3,471,295&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify;"&gt;Proceeds allocated to over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(160,600&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify;"&gt;Class A ordinary shares issuance at cost&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,604,847&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; padding-bottom: 1.5pt;"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;7,402,378&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify;"&gt;Class A ordinary shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;205,359,486&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-align: justify;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; padding-bottom: 1.5pt;"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,800,222&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 4pt;"&gt;Class A ordinary shares subject to possible redemption, June 30, 2026&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;207,159,708&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;           &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Net Income Per Ordinary Share&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary shares and Class&#160;B ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. Net income per ordinary share is calculated by dividing the net income&#160;by the weighted average ordinary shares outstanding for the respective period. The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the private placement of the Private Placement Units to receive an aggregate of&#160;10,411,266 ordinary shares in the calculation of diluted income (loss) per ordinary share, because the exercise of the warrants is contingent upon future events. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company considered the effect of 1,000,000 non-redeemable Class B ordinary shares that were subject to forfeiture contingent upon the extent of the exercise of the underwriters&#x2019; over-allotment option. Upon the partial exercise of the over-allotment option on February 2, 2026, 139,795 of these shares were no longer subject to forfeiture and were included in weighted-average shares outstanding from that date. The remaining 860,205 shares were subsequently surrendered to the Company for no consideration on March 11, 2026. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The following tables reflect&#160;the calculation of basic and diluted net income per ordinary share:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt;  June 30, 2026&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended &lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class&#160;A&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class B&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class&#160;A&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class B&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non - Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non - Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic and diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,248,127&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;406,989&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,984,797&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;773,193&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;20,873,579&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,806,462&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;17,406,850&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,780,975&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Basic and diluted income per share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the preparation of the Company&#x2019;s unaudited financial statements for the three and six months ended June 30, 2026, the Company identified an error in the calculation of weighted-average Class B ordinary shares outstanding for the three months ended March 31, 2026. Certain Founder Shares subject to forfeiture were incorrectly included in weighted-average shares outstanding prior to the resolution of the applicable forfeiture contingency. The correction resulted in a reallocation of net income between Class A and Class B ordinary shares and affected earnings per share but had no effect on total net income. The Company evaluated the error and concluded that it was not material, individually or in the aggregate, to the previously issued financial statements and that correction of the error was not material to the current-period financial statements. Accordingly, the affected prior-period amounts presented herein have been revised to correct the error.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;For the three months ended &lt;br/&gt; March 31, 2026&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;Adjustment&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;As Revised&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="width: 64%; text-align: left;"&gt;Class A &#x2013; Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;713,776&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;28,435&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;742,211&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class B &#x2013; Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;389,098&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;(28,435&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;360,663&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class A &#x2013; Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;13,901,600&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1883514860;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;13,901,600&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class B &#x2013; Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;7,578,130&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(822,926&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;6,755,204&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class A &#x2013; Basic and diluted EPS&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1844104598;"&gt;&lt;span style="-sec-ix-hidden:fc_1632770492;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class B &#x2013; Basic and diluted EPS&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_843280090;"&gt;&lt;span style="-sec-ix-hidden:fc_1832070373;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recent Issued Accounting Pronouncements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s unaudited financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="cref_1762077053" id="ixv-2101">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in unaudited financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The accompanying unaudited financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K. As of December 31, 2025 and for the period from September 16, 2025 (inception) through December 31, 2025, filed with the SEC on March 31, 2026. The interim results for the three and six months ended June 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <xsllu:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="cref_1762077053" id="ixv-2112">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Emerging Growth Company&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act&#160;of&#160;1933, as amended (the &#x201c;Securities Act&#x201d;), as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012, as amended (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act&#160;of&#160;2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;           &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s unaudited financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</xsllu:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="cref_1762077053" id="ixv-2136">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The preparation of unaudited financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited financial statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="cref_1762077053" id="ixv-2145">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company considers all short-term investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company had $1,750,553 and $&lt;span style="-sec-ix-hidden:fc_1218061301;"&gt;0&lt;/span&gt; of cash and no cash equivalents as of June 30, 2026 and December 31, 2025, respectively. &lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4861"
      unitRef="uref_2055607361">1750553</us-gaap:Cash>
    <xsllu:CashAndInvestmentsHeldInTrustAccountPolicyTextBlock contextRef="cref_1762077053" id="ixv-2153">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Investments Held in Trust Account&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; As of June 30, 2026, the assets held in the Trust Account, amounting to $207,159,708, were held in a money market account. As of December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_231689279;"&gt;no&lt;/span&gt; assets held in the Trust Account. &lt;/p&gt;</xsllu:CashAndInvestmentsHeldInTrustAccountPolicyTextBlock>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4862"
      unitRef="uref_2055607361">207159708</us-gaap:AssetsHeldInTrust>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="cref_1762077053" id="ixv-2161">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of June 30, 2026, the Company held cash balances in excess of federally insured limits. The Company has not experienced any losses on such accounts and management believes the Company is not exposed to significant risks on such accounts. &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:TimeDepositsAtOrAboveFDICInsuranceLimit
      contextRef="cref_2057164191"
      decimals="0"
      id="fc_1349554536"
      unitRef="uref_2055607361">250000</us-gaap:TimeDepositsAtOrAboveFDICInsuranceLimit>
    <xsllu:OfferingCostsPolicyTextBlock contextRef="cref_1762077053" id="ixv-2168">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Offering Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The Company complies with the requirements of the FASB ASC&#160;Topic 340-10-S99-1 and SEC Staff Accounting Bulletin Topic&#160;5A&#160;&#x2014;&#160;&#x201c;Expenses of Offering&#x201d; and Topic&#160;5T&#160;&#x2014;&#160;&#x201c;Accounting for Expenses or Liabilities Paid by Principal Shareholder(s).&#x201d; Offering costs consist of costs incurred in connection with preparation for the Initial Public Offering, which include professional and registration fees incurred. FASB ASC&#160;Topic 470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units&#160;between Class&#160;A ordinary shares and warrants, prorate, allocating the Initial Public Offering proceeds to the assigned value of the warrants and to the Class&#160;A ordinary shares. Offering costs allocated to the Public Shares are charged to temporary equity and offering costs allocated to the Public Warrants and Private Placement Units are charged to shareholders&#x2019; equity as Public Warrants and Private Placement Warrants included in the Private Placement Units after management&#x2019;s evaluation are accounted for under equity treatment.&lt;/p&gt;</xsllu:OfferingCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="cref_1762077053" id="ixv-2190">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company follows the asset and liability method of accounting for income taxes under FASB ASC&#160;Topic 740, &#x201c;Income Taxes.&#x201d; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the unaudited financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. FASB ASC&#160;Topic 740 prescribes a recognition threshold and a measurement attribute for the unaudited financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were &lt;span style="-sec-ix-hidden:fc_253127228;"&gt;&lt;span style="-sec-ix-hidden:fc_1614798136;"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_450433021;"&gt;&lt;span style="-sec-ix-hidden:fc_2084175086;"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties as of June 30, 2026 and December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s unaudited financial statements.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="cref_1762077053" id="ixv-2203">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;Topic 820, &#x201c;Fair Value Measurement,&#x201d; approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DerivativesPolicyTextBlock contextRef="cref_1762077053" id="ixv-2212">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Derivative Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging.&#x201d; For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12&#160;months of the balance sheet date. The underwriters&#x2019; over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and are accounted for as a liability pursuant to FASB ASC Topic 480 as the underwriters did not exercise their over-allotment option at the time of the Initial Public Offering. As of June 30, 2026, the underwriters&#x2019; over-allotment option has expired and, accordingly, no related liability is recognized in the Company&#x2019;s balance sheet.&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <xsllu:WarrantInstrumentsPolicyTextBlock contextRef="cref_1762077053" id="ixv-2219">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Warrant Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company accounts for the Public Warrants issued in connection with the Initial Public Offering and the Private Placement Warrants in accordance with the guidance contained in FASB ASC&#160;Topic 815, &#x201c;Derivatives and Hedging.&#x201d; Under FASB ASC&#160;Topic 815-40, the Public Warrants and the Private Placement Warrants included in the Private Placement Units meet the criteria for equity treatment and as such are recorded in shareholders&#x2019; equity. If the Public Warrants and Private Placement Warrants no longer meet the criteria for equity treatment, they will be recorded as a liability and remeasured each period with changes recorded in the unaudited statements of operations. As of June 30, 2026, there are 10,209,693 Public Warrants and 201,573 Private Placement Warrants issued and outstanding, reflecting the exercise of the underwriters&#x2019; over-allotment option. As of December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_972943973;"&gt;no&lt;/span&gt; Warrants outstanding. &lt;/p&gt;</xsllu:WarrantInstrumentsPolicyTextBlock>
    <xsllu:ClassOfWarrantOrRightIssued
      contextRef="cref_2113084492"
      decimals="0"
      id="ixv-4864"
      unitRef="uref_167372933">10209693</xsllu:ClassOfWarrantOrRightIssued>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_461618625"
      decimals="0"
      id="ixv-4865"
      unitRef="uref_167372933">10209693</us-gaap:ClassOfWarrantOrRightOutstanding>
    <xsllu:ClassOfWarrantOrRightIssued
      contextRef="cref_997179037"
      decimals="0"
      id="ixv-4866"
      unitRef="uref_167372933">201573</xsllu:ClassOfWarrantOrRightIssued>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_88531393"
      decimals="0"
      id="ixv-4867"
      unitRef="uref_167372933">201573</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="cref_1762077053" id="ixv-2242">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Share-Based Payment Arrangements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.45pt;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The Company accounts for share awards in accordance with FASB ASC Topic 718, &#x201c;Compensation&#x2014;Stock Compensation,&#x201d; which requires that all equity awards be accounted for at their &#x201c;fair value.&#x201d; Fair value is measured on the grant date and is equal to the underlying value of the share.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.45pt;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, in the period of grant for awards that vest immediately and have no future service condition, or in the period the awards vest immediately after meeting a performance condition becomes probable (i.e., the occurrence of a Business Combination). For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company&#x2019;s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is&#160;forfeited.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <xsllu:ClassAOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock contextRef="cref_1762077053" id="ixv-2251">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.45pt;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with FASB ASC Topic 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of the Public Shares will result in charges against additional paid-in capital (to the extent available) and then accumulated deficit. Accordingly, as of June 30, 2026, the 20,419,385 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; equity section of the Company&#x2019;s balance sheets. As of June 30, 2026, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table: &lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: justify;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;204,193,850&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify;"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(3,471,295&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify;"&gt;Proceeds allocated to over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(160,600&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify;"&gt;Class A ordinary shares issuance at cost&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,604,847&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; padding-bottom: 1.5pt;"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;7,402,378&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify;"&gt;Class A ordinary shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;205,359,486&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-align: justify;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; padding-bottom: 1.5pt;"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,800,222&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 4pt;"&gt;Class A ordinary shares subject to possible redemption, June 30, 2026&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;207,159,708&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</xsllu:ClassAOrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_251889792"
      decimals="0"
      id="ixv-4868"
      unitRef="uref_167372933">20419385</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="cref_1762077053" id="ixv-4869">As of June 30, 2026, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: justify;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;204,193,850&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify;"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(3,471,295&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify;"&gt;Proceeds allocated to over-allotment option&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(160,600&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify;"&gt;Class A ordinary shares issuance at cost&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,604,847&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: justify;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; padding-bottom: 1.5pt;"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;7,402,378&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify;"&gt;Class A ordinary shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;205,359,486&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-align: justify;"&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; padding-bottom: 1.5pt;"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,800,222&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 4pt;"&gt;Class A ordinary shares subject to possible redemption, June 30, 2026&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 4pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right;"&gt;207,159,708&lt;/td&gt; &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="cref_507656786"
      decimals="0"
      id="ixv-4870"
      unitRef="uref_2055607361">204193850</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="cref_507656786"
      decimals="0"
      id="ixv-4871"
      unitRef="uref_2055607361">3471295</us-gaap:ProceedsFromIssuanceOfWarrants>
    <xsllu:ProceedsAllocatedToOverallotmentOption
      contextRef="cref_507656786"
      decimals="0"
      id="ixv-4872"
      unitRef="uref_2055607361">-160600</xsllu:ProceedsAllocatedToOverallotmentOption>
    <xsllu:ClassAOrdinarySharesIssuanceAtCost
      contextRef="cref_507656786"
      decimals="0"
      id="ixv-4873"
      unitRef="uref_2055607361">-2604847</xsllu:ClassAOrdinarySharesIssuanceAtCost>
    <xsllu:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="cref_507656786"
      decimals="0"
      id="ixv-4874"
      unitRef="uref_2055607361">7402378</xsllu:RemeasurementOfCarryingValueToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_315117842"
      decimals="0"
      id="ixv-4875"
      unitRef="uref_2055607361">205359486</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <xsllu:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="cref_195483171"
      decimals="0"
      id="ixv-4876"
      unitRef="uref_2055607361">1800222</xsllu:RemeasurementOfCarryingValueToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4877"
      unitRef="uref_2055607361">207159708</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="cref_1762077053" id="ixv-2342">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Net Income Per Ordinary Share&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary shares and Class&#160;B ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. Net income per ordinary share is calculated by dividing the net income&#160;by the weighted average ordinary shares outstanding for the respective period. The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the private placement of the Private Placement Units to receive an aggregate of&#160;10,411,266 ordinary shares in the calculation of diluted income (loss) per ordinary share, because the exercise of the warrants is contingent upon future events. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company considered the effect of 1,000,000 non-redeemable Class B ordinary shares that were subject to forfeiture contingent upon the extent of the exercise of the underwriters&#x2019; over-allotment option. Upon the partial exercise of the over-allotment option on February 2, 2026, 139,795 of these shares were no longer subject to forfeiture and were included in weighted-average shares outstanding from that date. The remaining 860,205 shares were subsequently surrendered to the Company for no consideration on March 11, 2026. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The following tables reflect&#160;the calculation of basic and diluted net income per ordinary share:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt;  June 30, 2026&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended &lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class&#160;A&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class B&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class&#160;A&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class B&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non - Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non - Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic and diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,248,127&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;406,989&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,984,797&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;773,193&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;20,873,579&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,806,462&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;17,406,850&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,780,975&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Basic and diluted income per share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the preparation of the Company&#x2019;s unaudited financial statements for the three and six months ended June 30, 2026, the Company identified an error in the calculation of weighted-average Class B ordinary shares outstanding for the three months ended March 31, 2026. Certain Founder Shares subject to forfeiture were incorrectly included in weighted-average shares outstanding prior to the resolution of the applicable forfeiture contingency. The correction resulted in a reallocation of net income between Class A and Class B ordinary shares and affected earnings per share but had no effect on total net income. The Company evaluated the error and concluded that it was not material, individually or in the aggregate, to the previously issued financial statements and that correction of the error was not material to the current-period financial statements. Accordingly, the affected prior-period amounts presented herein have been revised to correct the error.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;For the three months ended &lt;br/&gt; March 31, 2026&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;Adjustment&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;As Revised&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="width: 64%; text-align: left;"&gt;Class A &#x2013; Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;713,776&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;28,435&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;742,211&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class B &#x2013; Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;389,098&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;(28,435&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;360,663&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class A &#x2013; Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;13,901,600&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1883514860;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;13,901,600&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class B &#x2013; Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;7,578,130&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(822,926&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;6,755,204&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class A &#x2013; Basic and diluted EPS&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1844104598;"&gt;&lt;span style="-sec-ix-hidden:fc_1632770492;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class B &#x2013; Basic and diluted EPS&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_843280090;"&gt;&lt;span style="-sec-ix-hidden:fc_1832070373;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt; </us-gaap:EarningsPerSharePolicyTextBlock>
    <xsllu:OrdinarySharesOfDiluted
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4878"
      unitRef="uref_167372933">10411266</xsllu:OrdinarySharesOfDiluted>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_1388846012"
      decimals="0"
      id="ixv-4879"
      unitRef="uref_167372933">1000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_1265438675"
      decimals="0"
      id="ixv-4880"
      unitRef="uref_167372933">139795</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <xsllu:SharesSurrenderedForNoConsideration
      contextRef="cref_96552065"
      decimals="0"
      id="ixv-4881"
      unitRef="uref_167372933">860205</xsllu:SharesSurrenderedForNoConsideration>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="cref_1762077053" id="ixv-2351">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The following tables reflect&#160;the calculation of basic and diluted net income per ordinary share:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt;  June 30, 2026&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended &lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class&#160;A&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class B&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class&#160;A&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Class B&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non - Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Non - Redeemable&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Basic and diluted net income per share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,248,127&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;406,989&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,984,797&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;773,193&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;20,873,579&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,806,462&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;17,406,850&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,780,975&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Basic and diluted income per share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_736587507"
      decimals="0"
      id="ixv-4882"
      unitRef="uref_2055607361">1248127</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1191056225"
      decimals="0"
      id="ixv-4883"
      unitRef="uref_2055607361">406989</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_732600868"
      decimals="0"
      id="ixv-4884"
      unitRef="uref_2055607361">1984797</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1446224866"
      decimals="0"
      id="ixv-4885"
      unitRef="uref_2055607361">773193</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_736587507"
      decimals="0"
      id="ixv-4886"
      unitRef="uref_167372933">20873579</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1191056225"
      decimals="0"
      id="ixv-4887"
      unitRef="uref_167372933">6806462</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_732600868"
      decimals="0"
      id="ixv-4888"
      unitRef="uref_167372933">17406850</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1446224866"
      decimals="0"
      id="ixv-4889"
      unitRef="uref_167372933">6780975</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_736587507"
      decimals="2"
      id="ixv-4890"
      unitRef="uref_461618625">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_736587507"
      decimals="2"
      id="ixv-4891"
      unitRef="uref_461618625">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1191056225"
      decimals="2"
      id="ixv-4892"
      unitRef="uref_461618625">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1191056225"
      decimals="2"
      id="ixv-4893"
      unitRef="uref_461618625">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_732600868"
      decimals="2"
      id="ixv-4894"
      unitRef="uref_461618625">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_732600868"
      decimals="2"
      id="ixv-4895"
      unitRef="uref_461618625">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1446224866"
      decimals="2"
      id="ixv-4896"
      unitRef="uref_461618625">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1446224866"
      decimals="2"
      id="ixv-4897"
      unitRef="uref_461618625">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock contextRef="cref_1762077053" id="ixv-4898">the affected prior-period amounts presented herein have been revised to correct the error.&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;For the three months ended &lt;br/&gt; March 31, 2026&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;Adjustment&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;As Revised&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="width: 64%; text-align: left;"&gt;Class A &#x2013; Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;713,776&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;28,435&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;742,211&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class B &#x2013; Allocation of net income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;389,098&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;(28,435&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;360,663&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class A &#x2013; Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;13,901,600&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1883514860;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;13,901,600&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class B &#x2013; Weighted-average shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;7,578,130&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(822,926&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;6,755,204&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class A &#x2013; Basic and diluted EPS&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1844104598;"&gt;&lt;span style="-sec-ix-hidden:fc_1632770492;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left; text-indent: -7.45pt; padding-left: 7.45pt;"&gt;Class B &#x2013; Basic and diluted EPS&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_843280090;"&gt;&lt;span style="-sec-ix-hidden:fc_1832070373;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.05&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;</us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_297007133"
      decimals="0"
      id="ixv-4899"
      unitRef="uref_2055607361">713776</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1124581008"
      decimals="0"
      id="ixv-4900"
      unitRef="uref_2055607361">28435</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_363545529"
      decimals="0"
      id="ixv-4901"
      unitRef="uref_2055607361">742211</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_780012692"
      decimals="0"
      id="ixv-4902"
      unitRef="uref_2055607361">389098</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_889404932"
      decimals="0"
      id="ixv-4903"
      unitRef="uref_2055607361">-28435</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_165842956"
      decimals="0"
      id="ixv-4904"
      unitRef="uref_2055607361">360663</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <xsllu:WeightedaverageSharesOutstanding
      contextRef="cref_297007133"
      decimals="0"
      id="ixv-4905"
      unitRef="uref_167372933">13901600</xsllu:WeightedaverageSharesOutstanding>
    <xsllu:WeightedaverageSharesOutstanding
      contextRef="cref_363545529"
      decimals="0"
      id="ixv-4906"
      unitRef="uref_167372933">13901600</xsllu:WeightedaverageSharesOutstanding>
    <xsllu:WeightedaverageSharesOutstanding
      contextRef="cref_780012692"
      decimals="0"
      id="ixv-4907"
      unitRef="uref_167372933">7578130</xsllu:WeightedaverageSharesOutstanding>
    <xsllu:WeightedaverageSharesOutstanding
      contextRef="cref_889404932"
      decimals="0"
      id="ixv-4908"
      unitRef="uref_167372933">-822926</xsllu:WeightedaverageSharesOutstanding>
    <xsllu:WeightedaverageSharesOutstanding
      contextRef="cref_165842956"
      decimals="0"
      id="ixv-4909"
      unitRef="uref_167372933">6755204</xsllu:WeightedaverageSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_297007133"
      decimals="2"
      id="ixv-4910"
      unitRef="uref_461618625">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_297007133"
      decimals="2"
      id="ixv-4911"
      unitRef="uref_461618625">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_363545529"
      decimals="2"
      id="ixv-4912"
      unitRef="uref_461618625">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_363545529"
      decimals="2"
      id="ixv-4913"
      unitRef="uref_461618625">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_780012692"
      decimals="2"
      id="ixv-4914"
      unitRef="uref_461618625">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_780012692"
      decimals="2"
      id="ixv-4915"
      unitRef="uref_461618625">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_165842956"
      decimals="2"
      id="ixv-4916"
      unitRef="uref_461618625">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_165842956"
      decimals="2"
      id="ixv-4917"
      unitRef="uref_461618625">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cref_1762077053" id="ixv-2621">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recent Issued Accounting Pronouncements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s unaudited financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <xsllu:InitialPublicOfferingDisclosureTextBlock contextRef="cref_1762077053" id="ixv-2628">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 3 &#x2014;&#160;INITIAL PUBLIC OFFERING&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; Pursuant to the Initial Public Offering on January 30, 2026, the Company sold 20,000,000&#160;Units,&#160;at a purchase price of $10.00 per Unit, generating gross proceeds of $200,000,000. On February 2, 2026, the Company consummated the closing of an additional 419,385 Units sold pursuant to the underwriters&#x2019; partial exercise of their over-allotment option, generating gross proceeds of $4,193,850. Each Unit consists of one Class A ordinary share and one-half of one Public Warrant. Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). &lt;/p&gt;</xsllu:InitialPublicOfferingDisclosureTextBlock>
    <xsllu:NumberOfUnitsIssued
      contextRef="cref_1666606632"
      decimals="0"
      id="ixv-4918"
      unitRef="uref_167372933">20000000</xsllu:NumberOfUnitsIssued>
    <xsllu:NumberOfUnitsIssuedPricePerShare
      contextRef="cref_1666606632"
      decimals="2"
      id="ixv-4919"
      unitRef="uref_461618625">10</xsllu:NumberOfUnitsIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1666606632"
      decimals="0"
      id="ixv-4920"
      unitRef="uref_2055607361">200000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <xsllu:NumberOfUnitsIssued
      contextRef="cref_2044190751"
      decimals="0"
      id="ixv-4921"
      unitRef="uref_167372933">419385</xsllu:NumberOfUnitsIssued>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_2044190751"
      decimals="0"
      id="ixv-4922"
      unitRef="uref_2055607361">4193850</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_994351911"
      decimals="0"
      id="ixv-4923"
      unitRef="uref_167372933">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <xsllu:NumberOfUnitsIssuedPricePerShare
      contextRef="cref_498423454"
      decimals="2"
      id="ixv-4924"
      unitRef="uref_461618625">11.5</xsllu:NumberOfUnitsIssuedPricePerShare>
    <xsllu:PrivatePlacementDisclosureTextBlock contextRef="cref_1762077053" id="ixv-2648">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 4 &#x2014;&#160;PRIVATE PLACEMENT&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 400,000&#160;Private Placement Units, at a price of $10.00 per Private Placement Unit, for an aggregate purchase price of $4,000,000 in a private placement. Simultaneously with the consummation of the partial exercise of over-allotment option on February 2, 2026, the Company also consummated the sale of an additional 3,146 Private Placement Units to the Sponsor, generating gross proceeds of $31,460. The Private Placement Units are identical to the Units sold in the Initial Public Offering, subject to certain limited exceptions as described in the Company&#x2019;s prospectus. The Private Placement Warrants included within the Private Placements Units are identical to the Public Warrants comprising part of the Units sold in the Initial Public Offering. Each whole Private Placement Warrant entitles the holder thereof to purchase one Class&#160;A ordinary share at a price of $11.50 per share, subject to adjustment, terms and limitations as described in the Company&#x2019;s prospectus. A portion of the proceeds from the Private Placement Units&#160;are added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units&#160;will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Units&#160;and all underlying securities will expire worthless. &lt;/p&gt;</xsllu:PrivatePlacementDisclosureTextBlock>
    <xsllu:NumberOfUnitsIssued
      contextRef="cref_626247227"
      decimals="0"
      id="ixv-4925"
      unitRef="uref_167372933">400000</xsllu:NumberOfUnitsIssued>
    <xsllu:NumberOfUnitsIssuedPricePerShare
      contextRef="cref_626247227"
      decimals="2"
      id="ixv-4926"
      unitRef="uref_461618625">10</xsllu:NumberOfUnitsIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_626247227"
      decimals="0"
      id="ixv-4927"
      unitRef="uref_2055607361">4000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <xsllu:NumberOfUnitsIssued
      contextRef="cref_1324287334"
      decimals="0"
      id="ixv-4928"
      unitRef="uref_167372933">3146</xsllu:NumberOfUnitsIssued>
    <xsllu:NetProceedsFromInitialPublicOffering
      contextRef="cref_1324287334"
      decimals="0"
      id="ixv-4929"
      unitRef="uref_2055607361">31460</xsllu:NetProceedsFromInitialPublicOffering>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_425230724"
      decimals="2"
      id="ixv-4930"
      unitRef="uref_461618625">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_1762077053" id="ixv-2655">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 5 &#x2014; RELATED PARTIES&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Founder Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; On September 16, 2025, the Sponsor received 9,583,333 of the Company&#x2019;s Class&#160;B ordinary shares (the &#x201c;Founder Shares&#x201d;) in exchange for a payment of $25,000 of the Company&#x2019;s expense to a vendor. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; On January 28, 2026, the Sponsor surrendered 1,916,666 Founder Shares to the Company for no consideration, resulting in the Sponsor holding an aggregate of 7,666,667 Founder Shares. All shares and per share amounts have been retroactively presented. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; Up to 1,000,000 Founder Shares will be surrendered to the Company for no consideration by the Sponsor depending on the extent to which the underwriters&#x2019; over-allotment option is exercised, so that the number of Founder Shares will collectively represent 20.0% of the Company&#x2019;s issued and outstanding shares upon the completion of the Initial Public Offering. On February 2, 2026, as a result of the partial exercise by the underwriters of the over-allotment option, 139,795 Founder Shares are no longer subject to forfeiture. On March 11, 2026, the underwriters forfeited the remaining unexercised balance of 2,580,615 over-allotment option Units. As a result, the Sponsor surrendered 860,205 Founder Shares to the Company for no consideration. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; On January 28, 2026, the Sponsor entered into agreement with directors and officers to transfer 73,334 Founder Shares to each of the Company&#x2019;s directors and officers (for an aggregate of 660,006 Founder Shares), at the same per-share price that the Sponsor purchased such Founder Shares, or approximately $0.003 per share in exchange for their services as independent directors and officers through the Company&#x2019;s initial Business Combination. The Founder Shares transferred were subject to several conditions under which the Sponsor held the same at the execution. The transfer of the Founder Shares to the holders is in the scope of FASB ASC Topic 718. Under FASB ASC Topic 718, share-based compensation associated with equity-classified awards is measured at fair value upon the assignment date. The total fair value of the 660,006 Founder Shares transferred to the holders on January 28, 2026, was $1,696,215 or $2.57 per share. The Company established the initial fair value of Founder Shares on January 28, 2026, the date of the grant agreement, using a calculation prepared by a third-party valuation experts which takes into consideration the implied Class A share price of $9.83, the probability of De-SPAC and market adjustment of 30.0%, selected discount for lack of marketability of 13.0%, and risk-free rate of 3.97%. The aggregate fair value of the Founder Shares transferred is classified as Level 3 at the measurement date due to the use of unobservable inputs, and other risk factors. The Founder Shares were assigned/transferred subject to a performance condition (i.e., providing services through Business Combination). Share-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founder Shares assigned/transferred times the assignment date fair value per share (unless subsequently modified) less the amount initially received for the shares, if there&#x2019;s any. As of June 30, 2026, the Company determined that the initial Business Combination is not considered probable and therefore no compensation expense has been recognized. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Sponsor, directors, and officers have agreed, subject to limited exceptions, not to transfer, assign or sell the Founder Shares until the earlier to occur of: (A)&#160;six&#160;months after completion of an initial Business Combination; or (B)&#160;if the closing price of the Company&#x2019;s ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing any time 150 days after completion of the initial Business Combination, (2) in the case of the Private Placement Units, including the Class A ordinary shares, and warrants comprising such Private Placement Units, and the respective Class A ordinary shares underlying such Private Placement Warrants, until 30 days after the completion of the initial Business Combination. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;General and Administrative Services&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company entered into an agreement with the Sponsor, commencing on January 28, 2026, the date that the Company&#x2019;s securities were first listed with Nasdaq, through the earlier of the Company&#x2019;s consummation of a Business Combination and its liquidation, to pay the Sponsor a monthly fee of $10,000 for office space, administrative and shared personnel support services. As of June 30, 2026, $51,290 has been accrued for these services in the Company&#x2019;s balance sheets. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Working Capital Loans&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;). The terms of such Working Capital Loans have not been determined, and no written agreements exist with respect to such loans. The Working Capital Loans may be repaid upon completion of a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to $1,500,000 of the Working Capital Loans may be converted upon completion of a Business Combination into units at a price of $10.00 per unit. Such units would be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of June 30, 2026 and December 31, 2025, there was no amount outstanding under the Working Capital Loans. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Promissory Note&#160;&#x2014;&#160;Related Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; On December 29, 2025, the Company entered into Amendment No. 1 to the promissory note (the &#x201c;Promissory Note&#x201d;) dated September 19, 2025 to extend the maturity of the Promissory Note to the earlier of (i) June 30, 2026 and (ii) the closing of the Initial Public Offering. The Sponsor agreed to loan the Company up to $2,000,000. These loans are non-interest bearing and unsecured. The Company had borrowed $316,235 under such Promissory Note, $316,235 of which has been paid by the Company at the closing of the Initial Public Offering and there was no amount outstanding. As of June 30, 2026, borrowings under the promissory note are no longer available. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Advance to Related Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;On February 4, 2026, the Company attempted to repay $7,610 outstanding under the Promissory Note to a related party. The payment was subsequently returned on March 4, 2026, resulting in an amount due to the related party of $7,610 as of March 31, 2026. The balance was subsequently settled through several transactions and related adjustments in April 2026. Following such settlement and related adjustments, the Company had a receivable from the related party of $45 as of June 30, 2026. The receivable is non-interest-bearing and is expected to be reimbursed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Due to Sponsor&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;From time to time, the Sponsor pays certain operating and offering costs on behalf of the Company. Such amounts are non-interest bearing, unsecured and payable on demand. As of June 30, 2026 and December 31, 2025, the balance due to the Sponsor was $100,000 and $&lt;span style="-sec-ix-hidden:fc_1447617457;"&gt;0&lt;/span&gt;, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Due to Related Parties&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;From time to time, certain related parties pay operating expenses on behalf of the Company. Such amounts are recorded as Due to related parties in the accompanying balance sheet. The balances are non-interest bearing, unsecured and payable on demand. As of June 30, 2026 and December 31, 2025, the balance due to related parties was $114,124 and $&lt;span style="-sec-ix-hidden:fc_853235104;"&gt;0&lt;/span&gt;, respectively.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:OtherReceivables
      contextRef="cref_1942716785"
      decimals="0"
      id="ixv-4931"
      unitRef="uref_2055607361">9583333</us-gaap:OtherReceivables>
    <us-gaap:OtherExpenses
      contextRef="cref_1683450615"
      decimals="0"
      id="ixv-4932"
      unitRef="uref_2055607361">25000</us-gaap:OtherExpenses>
    <xsllu:ShareSurrenderedForNoConsideration
      contextRef="cref_735942307"
      decimals="0"
      id="ixv-4933"
      unitRef="uref_167372933">1916666</xsllu:ShareSurrenderedForNoConsideration>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_107659405"
      decimals="0"
      id="ixv-4934"
      unitRef="uref_167372933">7666667</us-gaap:CommonStockSharesAuthorized>
    <xsllu:ShareSurrenderedForNoConsideration
      contextRef="cref_1451507070"
      decimals="0"
      id="fc_1024763223"
      unitRef="uref_167372933">1000000</xsllu:ShareSurrenderedForNoConsideration>
    <xsllu:PercentageOfIssuedAndOutstanding
      contextRef="cref_1451507070"
      decimals="3"
      id="ixv-4936"
      unitRef="uref_1495117848">0.20</xsllu:PercentageOfIssuedAndOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="cref_1635715959"
      decimals="0"
      id="ixv-4937"
      unitRef="uref_167372933">139795</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_642342285"
      decimals="0"
      id="ixv-4938"
      unitRef="uref_167372933">2580615</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <xsllu:StockIssuedDuringThePeriodNoLongerSubjectToForfeiture
      contextRef="cref_2032222852"
      decimals="0"
      id="ixv-4939"
      unitRef="uref_167372933">860205</xsllu:StockIssuedDuringThePeriodNoLongerSubjectToForfeiture>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1578264219"
      decimals="0"
      id="ixv-4940"
      unitRef="uref_167372933">73334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_826114678"
      decimals="0"
      id="ixv-4941"
      unitRef="uref_167372933">660006</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_107659405"
      decimals="3"
      id="ixv-4942"
      unitRef="uref_461618625">0.003</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="cref_735942307"
      decimals="0"
      id="ixv-4943"
      unitRef="uref_167372933">660006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="cref_1837092599"
      decimals="0"
      id="ixv-4944"
      unitRef="uref_2055607361">1696215</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="cref_1837092599"
      decimals="2"
      id="ixv-4945"
      unitRef="uref_461618625">2.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1657735904"
      decimals="2"
      id="ixv-4946"
      unitRef="uref_461618625">9.83</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="cref_723010644"
      decimals="3"
      id="ixv-4947"
      unitRef="uref_1495117848">0.30</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <xsllu:PercentageOfMarketability
      contextRef="cref_723010644"
      decimals="3"
      id="ixv-4948"
      unitRef="uref_1495117848">0.13</xsllu:PercentageOfMarketability>
    <xsllu:PercentageOfRiskFreeRate
      contextRef="cref_723010644"
      decimals="4"
      id="ixv-4949"
      unitRef="uref_1495117848">0.0397</xsllu:PercentageOfRiskFreeRate>
    <xsllu:ExceedsPricePerShare
      contextRef="cref_1762077053"
      decimals="2"
      id="ixv-4950"
      unitRef="uref_461618625">12</xsllu:ExceedsPricePerShare>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_1966811628"
      decimals="0"
      id="ixv-4951"
      unitRef="uref_2055607361">10000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4952"
      unitRef="uref_2055607361">51290</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <xsllu:WorkingCapitalLoans
      contextRef="cref_157639316"
      decimals="0"
      id="ixv-4953"
      unitRef="uref_2055607361">1500000</xsllu:WorkingCapitalLoans>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_81846091"
      decimals="2"
      id="ixv-4954"
      unitRef="uref_461618625">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_1916240742"
      decimals="0"
      id="ixv-4955"
      unitRef="uref_2055607361">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="cref_989617405"
      decimals="0"
      id="ixv-4956"
      unitRef="uref_2055607361">316235</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="cref_989617405"
      decimals="0"
      id="ixv-4957"
      unitRef="uref_2055607361">316235</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <xsllu:AdvanceToRelatedParty
      contextRef="cref_1664259452"
      decimals="0"
      id="fc_1664259452"
      unitRef="uref_2055607361">7610</xsllu:AdvanceToRelatedParty>
    <xsllu:AdvanceToRelatedParty
      contextRef="cref_1568216223"
      decimals="0"
      id="ixv-4959"
      unitRef="uref_2055607361">7610</xsllu:AdvanceToRelatedParty>
    <xsllu:AdvanceToRelatedParty
      contextRef="cref_210333060"
      decimals="0"
      id="ixv-4960"
      unitRef="uref_2055607361">45</xsllu:AdvanceToRelatedParty>
    <xsllu:DueToSponsor
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4961"
      unitRef="uref_2055607361">100000</xsllu:DueToSponsor>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4962"
      unitRef="uref_2055607361">114124</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cref_1762077053" id="fc_1937368240">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 6 &#x2014;&#160;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Registration Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The holders of the Founder Shares, Private Placement Units&#160;(including the securities comprising such Private Placement Units and the Class&#160;A ordinary shares issuable upon exercise of the Private Placement Warrants) and their permitted transferees are entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class&#160;A ordinary shares). The holders of these securities will be entitled to make up to three demands for underwritten offerings, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to the completion of an initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule&#160;415 under the Securities Act. Pursuant to such registration rights agreement, the Company has agreed that, within 30&#160;days after the consummation of an initial Business Combination, the Company will file with the SEC a registration statement registering the resale or other disposition of such securities. The Company will use its commercially reasonable efforts to cause such registration statement to become effective by the SEC as soon as reasonably practicable after the initial filing of the registration statement. The Company will bear the expenses incurred in connection with the filing of any such registration statements. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Underwriting Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 3,000,000 additional Units&#160;to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On February 2, 2026, the underwriters partially exercised their over-allotment option and purchased an additional 419,385 Units. The underwriters had 45 days from the date of the Initial Public Offering to purchase the remaining 2,580,615 over-allotment option Units. On March 11, 2026, the underwriters forfeited the remaining unexercised balance of 2,580,615 over-allotment option Units. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The underwriters were entitled to a cash underwriting discount of $0.075 per Unit or $1,500,000 in the aggregate, paid upon the closing of the Initial Public Offering. The underwriters were entitled to a cash underwriting discount of $0.075 per additional Unit or $31,454 in aggregate, paid on February 2, 2026 and the $6 has been transferred to the Company&#x2019;s bank operating account. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Representative Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company agreed to issue D. Boral, the representative of underwriters, 50,000 Class A ordinary shares upon the consummation of the Initial Public Offering (the &#x201c;Representative Shares&#x201d;). In connection with the partial exercise of the underwriters&#x2019; over-allotment option on February 2, 2026, the Company also agreed to issue an additional 1,048 Representative Shares to D. Boral. These Representative Shares were registered in the registration statement of which the prospectus forms a part. The representative of the underwriters has agreed not to transfer, assign or sell any such shares until the completion of an initial Business Combination. In addition, the representative of the underwriters has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of an initial Business Combination and (ii) to waive its rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete its initial Business Combination within the periods of time as provided in the Company&#x2019;s amended and restated memorandum and articles of association. The Representative Shares issued to D. Boral have been granted customary registration rights in compliance with FINRA Rule 5110(g)(8). &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the commencement of sales in the Initial Public Offering pursuant to FINRA Rule 5110(e)(1). Pursuant to this FINRA lock-up, these securities cannot be sold, transferred, assigned, pledged or hypothecated or the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days from the commencement of sales of the Initial Public Offering except as permitted under FINRA Rule 5110(e)(2), including to any underwriter and selected dealer participating in the offering and their officers or partners, registered persons or affiliates. These securities have resale registration rights including three demands (one at the Company&#x2019;s expense and two at D. Boral&#x2019;s expense) and unlimited &#x201c;piggy-back&#x201d; rights at any time, and from time to time. &lt;/p&gt;           &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Representative Shares issued to the representative of the underwriters are in the scope of FASB ASC Topic 718. Under FASB ASC Topic 718, stock-based compensation associated with equity-classified awards is measured at fair value on the grant date. Additionally, under Staff Accounting Bulletin Topic 5A, specific incremental costs directly attributable to proposed or actual offering of equity securities may be deferred and charged against the gross proceeds of the Initial Public Offering. The Company estimated the fair value of the 51,048 Representative Shares to be $501,802 or $9.83 per share. Accordingly, the fair value of $501,802 has been recorded as an offering cost which was closed to additional paid-in capital at the closing of the Initial Public Offering and the partial exercise of the underwriters&#x2019; over-allotment option. The Company established the initial fair value for the Representative Shares on January 30, 2026, the date of the issuance, using Monte Carlo Simulation Model prepared by a third-party valuation experts, which takes into consideration the probability of De-SPAC and market adjustment of 30.0%, selected discount for lack of marketability of 13.0%, risk-free rate of 3.97%, and selected volatility of 2.5%. &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <xsllu:PeriodToFileResaleRegistrationStatementAfterBusinessCombination contextRef="cref_1762077053" id="ixv-4963">P30D</xsllu:PeriodToFileResaleRegistrationStatementAfterBusinessCombination>
    <xsllu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1596325068"
      decimals="0"
      id="ixv-4964"
      unitRef="uref_167372933">3000000</xsllu:UnitsIssuedDuringPeriodSharesNewIssues>
    <xsllu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_2119870965"
      decimals="0"
      id="ixv-4965"
      unitRef="uref_167372933">419385</xsllu:UnitsIssuedDuringPeriodSharesNewIssues>
    <xsllu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1456379313"
      decimals="0"
      id="ixv-4966"
      unitRef="uref_167372933">2580615</xsllu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_96552065"
      decimals="0"
      id="ixv-4967"
      unitRef="uref_167372933">2580615</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <xsllu:CashUnderwritingDiscountPerUnits
      contextRef="cref_1209950440"
      decimals="3"
      id="ixv-4968"
      unitRef="uref_461618625">0.075</xsllu:CashUnderwritingDiscountPerUnits>
    <us-gaap:OtherUnderwritingExpense
      contextRef="cref_1456379313"
      decimals="0"
      id="ixv-4969"
      unitRef="uref_2055607361">1500000</us-gaap:OtherUnderwritingExpense>
    <xsllu:CashUnderwritingDiscountPerUnits
      contextRef="cref_1750857422"
      decimals="3"
      id="ixv-4970"
      unitRef="uref_461618625">0.075</xsllu:CashUnderwritingDiscountPerUnits>
    <us-gaap:OtherUnderwritingExpense
      contextRef="cref_1265438675"
      decimals="0"
      id="ixv-4971"
      unitRef="uref_2055607361">31454</us-gaap:OtherUnderwritingExpense>
    <xsllu:TransferredAmount
      contextRef="cref_1265438675"
      decimals="0"
      id="ixv-4972"
      unitRef="uref_2055607361">6</xsllu:TransferredAmount>
    <xsllu:RepresentativeShares
      contextRef="cref_238756345"
      decimals="0"
      id="ixv-4973"
      unitRef="uref_2055607361">50000</xsllu:RepresentativeShares>
    <xsllu:AdditionalRepresentativeShares
      contextRef="cref_1409571062"
      decimals="0"
      id="ixv-4974"
      unitRef="uref_167372933">1048</xsllu:AdditionalRepresentativeShares>
    <xsllu:RepresentativeSharesLockUpPeriodAfterSalesCommencement contextRef="cref_1762077053" id="ixv-4975">P180D</xsllu:RepresentativeSharesLockUpPeriodAfterSalesCommencement>
    <xsllu:LockUpPeriodRestrictionForRepresentativeShares contextRef="cref_1762077053" id="ixv-4976">P180D</xsllu:LockUpPeriodRestrictionForRepresentativeShares>
    <xsllu:RepresentativeShares
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4977"
      unitRef="uref_2055607361">51048</xsllu:RepresentativeShares>
    <xsllu:EstimatedFairValueOfRepresentativeShares
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4978"
      unitRef="uref_2055607361">501802</xsllu:EstimatedFairValueOfRepresentativeShares>
    <xsllu:EstimatedFairValuePerShareOfRepresentativeShares
      contextRef="cref_2057164191"
      decimals="2"
      id="ixv-4979"
      unitRef="uref_461618625">9.83</xsllu:EstimatedFairValuePerShareOfRepresentativeShares>
    <us-gaap:NoninterestExpenseOfferingCost
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-4980"
      unitRef="uref_2055607361">501802</us-gaap:NoninterestExpenseOfferingCost>
    <xsllu:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMarketAdjustmentRate
      contextRef="cref_1762077053"
      decimals="3"
      id="ixv-4981"
      unitRef="uref_1495117848">0.30</xsllu:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMarketAdjustmentRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
      contextRef="cref_1762077053"
      decimals="3"
      id="ixv-4982"
      unitRef="uref_1495117848">0.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="cref_1762077053"
      decimals="4"
      id="ixv-4983"
      unitRef="uref_1495117848">0.0397</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="cref_1762077053"
      decimals="3"
      id="ixv-4984"
      unitRef="uref_1495117848">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="cref_1762077053" id="ixv-2790">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 7 &#x2014;&#160;SHAREHOLDERS&#x2019; EQUITY (DEFICIT)&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Preference Shares&#160;&#x2014;&#160;&lt;/i&gt;&lt;/span&gt;The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors. As of June 30, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_696350577;"&gt;&lt;span style="-sec-ix-hidden:fc_904064709;"&gt;&lt;span style="-sec-ix-hidden:fc_647132504;"&gt;&lt;span style="-sec-ix-hidden:fc_679274483;"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; preference shares issued or outstanding. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;A Ordinary Shares&lt;/i&gt;&lt;/span&gt;&#160;&#x2014;&#160;The Company is authorized to issue 475,000,000 Class&#160;A ordinary shares with a par value of $0.0001 per share. Holders of Class&#160;A ordinary shares are entitled to one vote for each share. As of June 30, 2026 and December 31, 2025, there were 454,194 and &lt;span style="-sec-ix-hidden:fc_411385996;"&gt;&lt;span style="-sec-ix-hidden:fc_927632558;"&gt;no&lt;/span&gt;&lt;/span&gt; shares of Class&#160;A ordinary shares issued and outstanding, (excluding the 20,419,385 and &lt;span style="-sec-ix-hidden:fc_1385144039;"&gt;no&lt;/span&gt; shares of Class A ordinary shares subject to possible redemption), respectively. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;B Ordinary Shares&lt;/i&gt;&lt;/span&gt;&#160;&#x2014; The Company is authorized to issue 20,000,000 Class&#160;B ordinary shares with a par value of $0.0001 per share. Holders of Class&#160;B ordinary shares are entitled to one vote for each share. As of December 31, 2025, there were 7,666,667 Class&#160;B ordinary shares issued and outstanding, up to 1,000,000 of which will be surrendered to the Company for no consideration depending on the extent to which the underwriters&#x2019; over-allotment option is exercised. On February 2, 2026, as a result of the partial exercise by the underwriters of the over-allotment option, 139,795 Founder Shares are no longer subject to forfeiture. On March 11, 2026, the underwriters forfeited the remaining unexercised balance of 2,580,615 over-allotment option Units. As a result, the Sponsor surrendered 860,205 Founder Shares to the Company for no consideration. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Only holders of the Class B ordinary shares will have the right to vote on the appointment of directors and continuing the company in a jurisdiction outside the Cayman Islands prior to the Business Combination. Holders of ordinary shares will vote together as a single class on all matters submitted to a vote of the Company&#x2019;s shareholders except as otherwise required by law. In connection with an initial Business Combination, the Company may enter into shareholders&#x2019; agreement or other arrangements with the shareholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of the Initial Public Offering.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The Founder Shares are designated as Class&#160;B ordinary shares and will automatically convert at a ratio of one-for-one into Class&#160;A ordinary shares (which such Class&#160;A ordinary shares issued upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial Business Combination) at the time of an initial Business Combination or at any time prior thereto at the option of the holder thereof, subject to adjustments described herein.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-4985"
      unitRef="uref_167372933">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_2057164191"
      decimals="4"
      id="ixv-4986"
      unitRef="uref_461618625">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_251889792"
      decimals="0"
      id="ixv-4987"
      unitRef="uref_167372933">475000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_251889792"
      decimals="4"
      id="ixv-4988"
      unitRef="uref_461618625">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_251889792"
      decimals="0"
      id="ixv-4989"
      unitRef="uref_167372933">454194</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_251889792"
      decimals="0"
      id="ixv-4990"
      unitRef="uref_167372933">454194</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_251889792"
      decimals="0"
      id="ixv-4991"
      unitRef="uref_167372933">20419385</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1388846012"
      decimals="0"
      id="ixv-4992"
      unitRef="uref_167372933">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1388846012"
      decimals="4"
      id="ixv-4993"
      unitRef="uref_461618625">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1335978175"
      decimals="0"
      id="ixv-4994"
      unitRef="uref_167372933">7666667</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1335978175"
      decimals="0"
      id="ixv-4995"
      unitRef="uref_167372933">7666667</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
      contextRef="cref_993690049"
      decimals="0"
      id="ixv-4996"
      unitRef="uref_167372933">1000000</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
    <xsllu:SharesNotSubjectToForfeiture
      contextRef="cref_544972114"
      decimals="0"
      id="ixv-4997"
      unitRef="uref_167372933">139795</xsllu:SharesNotSubjectToForfeiture>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_96552065"
      decimals="0"
      id="ixv-4998"
      unitRef="uref_167372933">2580615</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <xsllu:StockIssuedDuringThePeriodNoLongerSubjectToForfeiture
      contextRef="cref_96552065"
      decimals="0"
      id="ixv-4999"
      unitRef="uref_167372933">860205</xsllu:StockIssuedDuringThePeriodNoLongerSubjectToForfeiture>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="cref_1762077053" id="ixv-2833">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 8 &#x2014; WARRANTS&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; There were 10,209,693 Public Warrants and 201,573 Private Placement Warrants issued and outstanding as of June 30, 2026, reflecting the exercise of the underwriters&#x2019; over-allotment option. There were &lt;span style="-sec-ix-hidden:fc_285154315;"&gt;no&lt;/span&gt; Warrants outstanding as of December 31, 2025. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination and (b) 12&#160;months from the closing of the Initial Public Offering. The Public Warrants will expire five&#160;years after the completion of a Business Combination or earlier upon redemption or liquidation. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The Company will not be obligated to deliver any Class&#160;A ordinary share pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class&#160;A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class&#160;A ordinary shares is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company has agreed that as soon as practicable, but in no event later than 20&#160;business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed. Notwithstanding the above, if the Class A ordinary share is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a &#x201c;covered security&#x201d; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; Redemption of warrants when the price per Class&#160;A ordinary share equals or exceeds $18.00 &#x2014;&#160;Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-align: justify; text-indent: -19.45pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in; text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;in whole and not in part;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-align: justify; text-indent: -19.45pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in; text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;at a price of $0.01 per Public Warrant;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-align: justify; text-indent: -19.45pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in; text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;upon a minimum of 30&#160;days&#x2019; prior written notice of redemption, or the 30-day redemption period to each warrant holder;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-align: justify; text-indent: -19.45pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in; text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;if, and only if, the last reported sale price of the Class&#160;A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share dividends, reorganization, recapitalizations and the like); and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-align: justify; text-indent: -19.45pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in; text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;for any 10&#160;trading days within a 20-trading&#160;day period ending on the third&#160;trading day prior to the date on which the Company sends the notice of redemption to warrant holders.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; If the Company calls the warrants for redemption as described in this paragraph, its management will have the option to require any holder that wishes to exercise their warrant following the notice of redemption to do so on a cashless basis. In the case of such a cashless exercise, each holder would pay the exercise price by surrendering the Public Warrants for that number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the product of the number of Class&#160;A ordinary shares underlying the warrants, multiplied by the excess of the &#x201c;fair market value&#x201d; less the exercise price of the warrants by (y)&#160;the fair market value. The &#x201c;fair market value&#x201d; as used in the preceding sentence shall mean the volume weighted average price of the Class&#160;A ordinary shares for the 10&#160;trading days ending on the&#160;trading day prior to the date on which the notice of redemption is sent to the holders of the public warrants. If its management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of Class&#160;A ordinary shares to be received upon exercise of the warrants, including the &#x201c;fair market value&#x201d; in such case. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company has established the $18.00 per share (as adjusted) redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the public warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the Public Warrants, each Public Warrant holder will be entitled to exercise his, her or its Public Warrant prior to the scheduled redemption date. However, the price of the Class&#160;A ordinary shares may fall below the $18.00 redemption trigger price, as well as the $11.50 Public Warrant exercise price after the redemption notice is issued. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; In addition, if (x)&#160;the Company issues additional Class&#160;A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at less than $9.20 per Class&#160;A ordinary share (with such issue price or effective issue price to be determined in good faith by its board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or its affiliates, as applicable, prior to such issuance) (the &#x201c;Newly Issued Price&#x201d;), (y)&#160;the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of its initial Business Combination on the date of the completion of its initial Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of Class&#160;A ordinary shares during the 20&#160;day trading period starting on the&#160;trading day prior to the&#160;day on which the Company consummates its initial Business Combination (such price, the &#x201c;Market Value&#x201d;) is below $9.20 per share, then the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to&#160;the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Private Placement Warrants included in the Private Placement Units are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class&#160;A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30&#160;days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cash or cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. &lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <xsllu:ClassOfWarrantOrRightIssued
      contextRef="cref_2113084492"
      decimals="0"
      id="ixv-5000"
      unitRef="uref_167372933">10209693</xsllu:ClassOfWarrantOrRightIssued>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_461618625"
      decimals="0"
      id="ixv-5001"
      unitRef="uref_167372933">10209693</us-gaap:ClassOfWarrantOrRightOutstanding>
    <xsllu:ClassOfWarrantOrRightIssued
      contextRef="cref_997179037"
      decimals="0"
      id="ixv-5002"
      unitRef="uref_167372933">201573</xsllu:ClassOfWarrantOrRightIssued>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_88531393"
      decimals="0"
      id="ixv-5003"
      unitRef="uref_167372933">201573</us-gaap:ClassOfWarrantOrRightOutstanding>
    <xsllu:PeriodOfWarrantsAfterPublicOffering contextRef="cref_2113084492" id="ixv-5004">P12M</xsllu:PeriodOfWarrantsAfterPublicOffering>
    <xsllu:MaximumPeriodForFilingAfterBusinessCombination contextRef="cref_1762077053" id="ixv-5005">P20D</xsllu:MaximumPeriodForFilingAfterBusinessCombination>
    <xsllu:NumberOfDaysToDeclareLegalEffectivenessAfterRegistration contextRef="cref_1762077053" id="ixv-5006">P60D</xsllu:NumberOfDaysToDeclareLegalEffectivenessAfterRegistration>
    <us-gaap:SharePrice
      contextRef="cref_977440093"
      decimals="2"
      id="ixv-5007"
      unitRef="uref_461618625">18</us-gaap:SharePrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1539524353"
      decimals="2"
      id="ixv-5008"
      unitRef="uref_461618625">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <xsllu:MinimumNoticePeriodForRedemptionOfWarrants contextRef="cref_1867110348" id="ixv-5009">P30D</xsllu:MinimumNoticePeriodForRedemptionOfWarrants>
    <xsllu:RedemptionPeriodAllocatedToWarrantHolders contextRef="cref_1867110348" id="ixv-5010">P30D</xsllu:RedemptionPeriodAllocatedToWarrantHolders>
    <us-gaap:SharePrice
      contextRef="cref_977440093"
      decimals="2"
      id="ixv-5011"
      unitRef="uref_461618625">18</us-gaap:SharePrice>
    <xsllu:MinimumTradingDaysForMeetingSharePriceCondition contextRef="cref_1867110348" id="ixv-5012">P10D</xsllu:MinimumTradingDaysForMeetingSharePriceCondition>
    <xsllu:MeasurementPeriodForConsideringSharePriceCondition contextRef="cref_1867110348" id="ixv-5013">P20D</xsllu:MeasurementPeriodForConsideringSharePriceCondition>
    <xsllu:VolumeWeightedAveragePriceCalculationPeriod contextRef="cref_1171897513" id="ixv-5014">P10D</xsllu:VolumeWeightedAveragePriceCalculationPeriod>
    <xsllu:SharePriceThresholdForWarrantRedemptionEligibility
      contextRef="cref_1762077053"
      decimals="2"
      id="ixv-5015"
      unitRef="uref_461618625">18</xsllu:SharePriceThresholdForWarrantRedemptionEligibility>
    <xsllu:SharePriceRedemptionTriggerForPublicWarrants
      contextRef="cref_1171897513"
      decimals="2"
      id="ixv-5016"
      unitRef="uref_461618625">18</xsllu:SharePriceRedemptionTriggerForPublicWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1976784221"
      decimals="2"
      id="ixv-5017"
      unitRef="uref_461618625">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <xsllu:MaximumExpectedPricePerShareUponNewIssuance
      contextRef="cref_1171897513"
      decimals="2"
      id="ixv-5018"
      unitRef="uref_461618625">9.2</xsllu:MaximumExpectedPricePerShareUponNewIssuance>
    <xsllu:PercentageOfGrossProceedsEquityIssuances
      contextRef="cref_1171897513"
      decimals="2"
      id="ixv-5019"
      unitRef="uref_1495117848">0.60</xsllu:PercentageOfGrossProceedsEquityIssuances>
    <xsllu:TradingPeriodForMarketValueCalculation contextRef="cref_1171897513" id="ixv-5020">P20D</xsllu:TradingPeriodForMarketValueCalculation>
    <xsllu:MarketValueThresholdForWarrantAdjustment
      contextRef="cref_1171897513"
      decimals="2"
      id="ixv-5021"
      unitRef="uref_461618625">9.2</xsllu:MarketValueThresholdForWarrantAdjustment>
    <xsllu:WarrantExercisePriceAdjustmentPercentageOnMarketValue
      contextRef="cref_1171897513"
      decimals="2"
      id="ixv-5022"
      unitRef="uref_1495117848">1.15</xsllu:WarrantExercisePriceAdjustmentPercentageOnMarketValue>
    <xsllu:PublicWarrantRedemptionTriggerPricePerShare
      contextRef="cref_1171897513"
      decimals="2"
      id="ixv-5023"
      unitRef="uref_461618625">18</xsllu:PublicWarrantRedemptionTriggerPricePerShare>
    <xsllu:AdjustedRedemptionTriggerPricePercentageOnMarketValue
      contextRef="cref_1171897513"
      decimals="2"
      id="ixv-5024"
      unitRef="uref_1495117848">1.80</xsllu:AdjustedRedemptionTriggerPricePercentageOnMarketValue>
    <xsllu:RestrictionPeriodForWarrantsAfterCompletionOfBusinessCombination contextRef="cref_1503113034" id="ixv-5025">P30D</xsllu:RestrictionPeriodForWarrantsAfterCompletionOfBusinessCombination>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cref_1762077053" id="ixv-2916">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 9 &#x2014;&#160;SEGMENT INFORMATION&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;FASB ASC Topic&#160;280, &#x201c;Segment Reporting,&#x201d; establishes standards for companies to report, in their unaudited financial statements, information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company&#x2019;s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) has been identified as the &lt;span style="-sec-ix-hidden:fc_1393846306;"&gt;Chief Financial Officer&lt;/span&gt;, who uses net income as the primary measure of segment profit or loss to assess performance and allocate resources. The CODM also reviews the Company&#x2019;s assets, operating results and other financial metrics in evaluating the Company&#x2019;s financial performance. Accordingly, management has determined that the Company operates as a &lt;span style="-sec-ix-hidden:fc_1375488483;"&gt;single&lt;/span&gt; reportable segment. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The measure of segment profit or loss is reported in the statements of operations as net income. The measure of segment assets is reported on the balance sheets as total assets. In addition to net income and total assets, the CODM reviews several key metrics, which include the following:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Cash and investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;207,159,708&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden:fc_327851401;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-indent: -8.1pt; padding-left: 8.1pt;"&gt;Cash&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,750,553&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_125873775;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;For the&lt;br/&gt; Three Months Ended&lt;br/&gt; June 30,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;For the&lt;br/&gt; Six Months Ended&lt;br/&gt; June 30,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="width: 76%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt;"&gt;Formation, general, and administrative costs&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;145,106&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;368,468&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt;"&gt;Interest earned on cash and investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,800,222&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,965,858&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The CODM reviews formation, general, and administrative costs to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Business Combination period. The CODM also reviews formation, general, and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Formation, general, and administrative costs, as reported on the unaudited statement of operation, are the significant segment expenses provided to the CODM on a regular basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The CODM reviews the position of total assets as reported in the Company&#x2019;s balance sheets to assess if the Company has sufficient resources available to discharge its liabilities. The CODM is provided with details of cash and liquid resources available with the Company. The CODM will review the interest that will be earned and accrued on cash and investments held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_1762077053" id="ixv-2938">The Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) has been identified as the Chief Financial Officer, who uses net income as the primary measure of segment profit or loss to assess performance and allocate resources. The CODM also reviews the Company&#x2019;s assets, operating results and other financial metrics in evaluating the Company&#x2019;s financial performance. Accordingly, management has determined that the Company operates as a single reportable segment.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="cref_1762077053" id="ixv-5026">The measure of segment assets is reported on the balance sheets as total assets. In addition to net income and total assets, the CODM reviews several key metrics, which include the following:&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Cash and investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;207,159,708&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden:fc_327851401;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-indent: -8.1pt; padding-left: 8.1pt;"&gt;Cash&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,750,553&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_125873775;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;For the&lt;br/&gt; Three Months Ended&lt;br/&gt; June 30,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;For the&lt;br/&gt; Six Months Ended&lt;br/&gt; June 30,&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td style="width: 76%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt;"&gt;Formation, general, and administrative costs&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;145,106&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;368,468&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left; text-indent: -8.1pt; padding-left: 8.1pt;"&gt;Interest earned on cash and investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,800,222&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,965,858&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-5027"
      unitRef="uref_2055607361">207159708</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Cash
      contextRef="cref_2057164191"
      decimals="0"
      id="ixv-5028"
      unitRef="uref_2055607361">1750553</us-gaap:Cash>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_195483171"
      decimals="0"
      id="ixv-5029"
      unitRef="uref_2055607361">145106</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-5030"
      unitRef="uref_2055607361">368468</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_195483171"
      decimals="0"
      id="ixv-5031"
      unitRef="uref_2055607361">1800222</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_1762077053"
      decimals="0"
      id="ixv-5032"
      unitRef="uref_2055607361">2965858</us-gaap:InvestmentIncomeInterest>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="cref_1762077053" id="ixv-3027">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 10 &#x2014; FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.45pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.45pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level 1:&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level 2:&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level 3:&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The following table presents information about the Company&#x2019;s assets that are measured at fair value as of June 30, 2026 and December 31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.15pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Level&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: justify;"&gt;Assets:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 64%; text-align: justify;"&gt;Cash and investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;207,159,708&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1850072397;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.15pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt; The fair value of the 10,209,693 Public Warrants issued in connection with the Initial Public Offering, including the underwriters&#x2019; partial exercise of the over-allotment option, was approximately $3,471,295, or $0.34 per Public Warrant. The Public Warrants issued in the Initial Public Offering have been classified within additional paid-in capital in shareholders&#x2019; equity and will not require remeasurement after issuance. The valuation assumptions presented below were applied to the Public Warrants issued on January 30, 2026 and the additional Public Warrants issued upon the partial exercise of the underwriters&#x2019; over-allotment option on February 2, 2026. The following table presents the quantitative information regarding the market assumptions used in the Level 3 valuation of the Public Warrants issued in the Initial Public Offering: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;January 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Implied Class A ordinary share price&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;9.83&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Exercise price&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;11.50&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Expected term to De-SPAC&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;2 years&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Warrant term&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;7 years&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Selected volatility&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;2.50&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Probability of De-SPAC and market adjustment&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;30.00&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Risk-free rate (continuous)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;3.97&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="cref_1762077053" id="ixv-3077">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The following table presents information about the Company&#x2019;s assets that are measured at fair value as of June 30, 2026 and December 31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.15pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: justify;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;Level&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: justify;"&gt;Assets:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 64%; text-align: justify;"&gt;Cash and investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;207,159,708&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1850072397;"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_2115185240"
      decimals="0"
      id="ixv-5033"
      unitRef="uref_2055607361">207159708</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_461618625"
      decimals="0"
      id="ixv-5034"
      unitRef="uref_167372933">10209693</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="cref_461618625"
      decimals="0"
      id="ixv-5035"
      unitRef="uref_2055607361">3471295</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_461618625"
      decimals="2"
      id="ixv-5036"
      unitRef="uref_461618625">0.34</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="cref_1762077053" id="ixv-5037">The following table presents the quantitative information regarding the market assumptions used in the Level 3 valuation of the Public Warrants issued in the Initial Public Offering:&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;January 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Implied Class A ordinary share price&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;9.83&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Exercise price&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;11.50&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Expected term to De-SPAC&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;2 years&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Warrant term&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;7 years&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Selected volatility&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;2.50&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Probability of De-SPAC and market adjustment&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;30.00&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; text-indent: -7.25pt; padding-left: 7.25pt;"&gt;Risk-free rate (continuous)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;3.97&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_471804980"
      decimals="2"
      id="ixv-5038"
      unitRef="uref_1495117848">9.83</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_696371864"
      decimals="2"
      id="ixv-5039"
      unitRef="uref_1495117848">11.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1196578209"
      decimals="0"
      id="ixv-5040"
      unitRef="uref_1495117848">2</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1756716729"
      decimals="0"
      id="ixv-5041"
      unitRef="uref_1495117848">7</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_319446629"
      decimals="4"
      id="ixv-5042"
      unitRef="uref_1495117848">0.025</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1045493571"
      decimals="4"
      id="ixv-5043"
      unitRef="uref_1495117848">0.30</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1495117848"
      decimals="4"
      id="ixv-5044"
      unitRef="uref_1495117848">0.0397</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_1762077053" id="ixv-3179">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 11 &#x2014; SUBSEQUENT EVENTS&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;The Company evaluated subsequent events and transactions that occurred after the balance sheet date and through the date the unaudited financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_1762077053" id="ixv-5045">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_1762077053" id="ixv-5046">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_1762077053" id="ixv-5047">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_1762077053" id="ixv-5048">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#fc_1510873683"
          xlink:label="fc_1510873683"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_831437636"
          xlink:label="fc_831437636"
          xlink:type="locator"/>
        <link:footnote id="fref_559636314" xlink:label="fref_559636314" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of December 31, 2025, up to 1,000,000 Founder Shares were subject to forfeiture depending on the extent to which the underwriters&#x2019; over-allotment option was exercised. On February 2, 2026, upon the partial exercise of the over-allotment option, 139,795 Founder Shares were no longer subject to forfeiture. On March 11, 2026, the Sponsor surrendered the remaining 860,205 Founder Shares to the Company for no consideration upon expiration of the unexercised portion of the over-allotment option.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1510873683"
          xlink:to="fref_559636314"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_831437636"
          xlink:to="fref_559636314"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_278179953"
          xlink:label="fc_278179953"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_306520301"
          xlink:label="fc_306520301"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1275346653"
          xlink:label="fc_1275346653"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1120036541"
          xlink:label="fc_1120036541"
          xlink:type="locator"/>
        <link:footnote id="fref_1080994280" xlink:label="fref_1080994280" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of December 31, 2025, up to 1,000,000 Founder Shares were subject to forfeiture depending on the extent to which the underwriters&#x2019; over-allotment option was exercised. On February 2, 2026, upon the partial exercise of the over-allotment option, 139,795 Founder Shares were no longer subject to forfeiture. On March 11, 2026, the Sponsor surrendered the remaining 860,205 Founder Shares to the Company for no consideration upon expiration of the unexercised portion of the over-allotment option.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_278179953"
          xlink:to="fref_1080994280"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_306520301"
          xlink:to="fref_1080994280"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1275346653"
          xlink:to="fref_1080994280"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1120036541"
          xlink:to="fref_1080994280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1721558185"
          xlink:label="fc_1721558185"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_522668487"
          xlink:label="fc_522668487"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_740609882"
          xlink:label="fc_740609882"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_880030228"
          xlink:label="fc_880030228"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_107669114"
          xlink:label="fc_107669114"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1231923650"
          xlink:label="fc_1231923650"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_791282151"
          xlink:label="fc_791282151"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1583060497"
          xlink:label="fc_1583060497"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_396571739"
          xlink:label="fc_396571739"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1211145252"
          xlink:label="fc_1211145252"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1240357674"
          xlink:label="fc_1240357674"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_2083409104"
          xlink:label="fc_2083409104"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_415702717"
          xlink:label="fc_415702717"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1478212138"
          xlink:label="fc_1478212138"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_245339642"
          xlink:label="fc_245339642"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1930866084"
          xlink:label="fc_1930866084"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1129424118"
          xlink:label="fc_1129424118"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1963566780"
          xlink:label="fc_1963566780"
          xlink:type="locator"/>
        <link:footnote id="fref_1252897925" xlink:label="fref_1252897925" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of December 31, 2025, up to 1,000,000 Founder Shares were subject to forfeiture depending on the extent to which the underwriters&#x2019; over-allotment option was exercised. On February 2, 2026, upon the partial exercise of the over-allotment option, 139,795 Founder Shares were no longer subject to forfeiture. On March 11, 2026, the Sponsor surrendered the remaining 860,205 Founder Shares to the Company for no consideration upon expiration of the unexercised portion of the over-allotment option.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1721558185"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_522668487"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_740609882"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_880030228"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_107669114"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1231923650"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_791282151"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1583060497"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_396571739"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1211145252"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1240357674"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2083409104"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_415702717"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1478212138"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_245339642"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1930866084"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1129424118"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1963566780"
          xlink:to="fref_1252897925"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
